Open research · Psilocybin & psilocin

Countries and organisations

Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.

Free access · No subscription for research tools or data exports

Explore registry geography and organisations

Trial, condition or NCT IDCountrySponsorPhaseStatusConditionReset

310 trials match this view; 474 reported facilities; 470 have usable coordinates. Latest indexed registry check Oct 30, 2026 02:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 15,282 across 310 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Export filtered registry facts · JSONInteractive world map Germany source-checked report

Recorded study-start years

200411

200711

200811

200922

201222

201322

201433

201533

201611

201755

201844

201999

20201010

20212525

20222424

20234040

20244949

20255252

20266767

202788

202911

Current indexed registry status

Recruiting104104

Completed9797

Active, not recruiting3434

Not yet recruiting3333

Unknown status1616

Withdrawn1414

Terminated77

Enrolling by invitation33

Suspended22

Reported research conditions

Healthy2626

Depression2323

Major Depressive Disorder2323

Treatment Resistant Depression2020

Anxiety1313

PTSD1313

Alcohol Use Disorder1313

Psilocybin1212

Psychedelic Experiences99

Opioid Use Disorder99

Post Traumatic Stress Disorder77

Depression - Major Depressive Disorder77

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Countries with reported trial locations

United States184184

Canada4141

Switzerland2121

United Kingdom1818

France77

Denmark77

Netherlands66

Czechia55

Ireland55

Sweden44

Israel44

Australia33

Germany33

Spain22

Brazil22

Pakistan22

Portugal22

Belgium22

Poland11

Austria11

New Zealand11

Finland11

Jordan11

Jamaica11

Argentina11

Matching trial records

310 matching registry records. Dates are registry milestones, not promised results announcements.
Trial	Sponsor and phase	Status	Enrollment	Start / primary completion / completion	Research workflow
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease NCT07721467 Alzheimer's Disease	National Institute on Aging (NIA) PHASE2	Recruiting Registry updated 2026-10-29	200 ESTIMATED	2026-11-03 2030-12-31 2030-12-31
A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer. NCT07072728 Adjustment Disorder · Adjustment Disorder With Anxious Mood · Cancer · Cancer Cachexia · Cancer of Endometrium · Cancer of Kidney · Cancer of Prostate · Cancer of the Breast · Cancer of Stomach · Cancer Melanoma Skin · Cancer Pancreas	Psyence Australia Pty Ltd PHASE2	Recruiting Registry updated 2026-10-29	87 ESTIMATED	2025-10-01 2027-03-30 2027-12-30
A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression NCT07336238 Anxiety · Depression · Hematopoietic and Lymphatic System Neoplasm · Metastatic Malignant Solid Neoplasm	University of Washington PHASE2	Active, not recruiting Registry updated 2026-10-29	16 ACTUAL	2026-05-19 2026-12-01 2027-05-01
An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder NCT05399498 Borderline Personality Disorder · Major Depressive Disorder	University of Chicago PHASE2	Completed Registry updated 2026-10-29	10 ACTUAL	2023-11-01 2025-12-01 2025-12-01	Posted registry results
Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer NCT06001749 Opioid-Related Disorders · Pain Management · Pain Management and Care · Advanced Cancer · Advanced Cancers	Yvan Beaussant, MD, MSci PHASE2	Active, not recruiting Registry updated 2026-10-27	15 ESTIMATED	2024-09-23 2026-10-01 2026-12-31
Safety, Efficacy, and Mechanisms of Psilocybin-assisted Acceptance and Commitment Therapy (PACT) in Treating Major Depressive Disorder (MDD) Among Veterans NCT07895134 Major Depression	VA Office of Research and Development PHASE2	Not yet recruiting Registry updated 2026-10-26	150 ESTIMATED	2027-01-01 2031-12-31 2031-12-31
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial NCT07405606 Major Depressive Disorder (MDD) · Alcohol Use Disorder (AUD)	Centre for Addiction and Mental Health PHASE2	Recruiting Registry updated 2026-10-26	30 ESTIMATED	2026-03-23 2028-03 2028-06
Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism NCT06731621 Treatment Resistant Depression · Autism Spectrum Disorder	Centre for Addiction and Mental Health PHASE1	Active, not recruiting Registry updated 2026-10-26	18 ACTUAL	2024-11-01 2027-01 2027-01
Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes NCT07306364 Chronic Low Back Pain (CLBP) · Physical Therapy · Psilocybin	Yale University PHASE2	Not yet recruiting Registry updated 2026-10-26	48 ESTIMATED	2026-12 2029-06 2029-06
A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder NCT07570654 PTSD - Post Traumatic Stress Disorder · PTSD · PTSD Symptoms · PTSD, Post Traumatic Stress Disorder	COMPASS Pathways PHASE2, PHASE3	Recruiting Registry updated 2026-10-23	300 ESTIMATED	2026-09 2028-11 2029-09
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder NCT07499583 Treatment Resistant Depression · Substance Use Disorders	Indiana University PHASE1, PHASE2	Not yet recruiting Registry updated 2026-10-23	50 ESTIMATED	2027-02-01 2031-02-01 2031-02-01
A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans NCT07226232 Major Depression	VA Office of Research and Development PHASE3	Recruiting Registry updated 2026-10-23	240 ESTIMATED	2026-08-03 2030-12-02 2031-06-30
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD) NCT06308653 Depressive Disorder, Major	Usona Institute PHASE3	Active, not recruiting Registry updated 2026-10-21	238 ACTUAL	2024-03-13 2026-01-05 2027-01-30
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial NCT06518720 Treatment Resistant Depression · Chronic Pain	Centre for Addiction and Mental Health PHASE2	Recruiting Registry updated 2026-10-21	16 ESTIMATED	2025-04-01 2027-03 2027-12
A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety NCT06820723 Depression · Anxiety · Major Depressive Disorder	Ohio State University PHASE2	Recruiting Registry updated 2026-10-20	40 ESTIMATED	2026-11-01 2028-11 2028-11	Registry-linked result · PMID 27210031 Registry-linked result · PMID 33146667 Registry-linked result · PMID 36322843 Registry-linked result · PMID 31060042 Registry-linked result · PMID 31636488 Registry-linked result · PMID 37651119 Registry-linked result · PMID 27909164 Registry-linked result · PMID 20717121
Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin NCT05866471 Healthy · Psychedelic Experiences · Vagus Nerve Stimulation	University of Wisconsin, Madison PHASE1	Recruiting Registry updated 2026-10-20	115 ESTIMATED	2025-01-27 2027-11 2028-01
Microdosing Psychedelics to Improve Mood NCT05259943 Major Depressive Disorder	Rotem Petranker PHASE2	Completed Registry updated 2026-10-20	39 ACTUAL	2023-07-15 2024-12-21 2025-02-01
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST) NCT06512220 Treatment Resistant Depression	Centre for Addiction and Mental Health PHASE2	Recruiting Registry updated 2026-10-19	12 ESTIMATED	2025-04-21 2027-04 2027-09
A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD) NCT07104916 Post Traumatic Stress Disorder · Depression - Major Depressive Disorder	Anthony P King PHASE2	Recruiting Registry updated 2026-10-19	30 ESTIMATED	2026-09-01 2029-09 2029-12
The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin NCT07877987 Psilocybin Intoxication	Johns Hopkins University PHASE1	Not yet recruiting Registry updated 2026-10-16	80 ESTIMATED	2027-03-01 2030-06-30 2030-06-30
Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial NCT05554094 PTSD · Stress Disorders, Traumatic · Stress Disorders, Post-Traumatic · Trauma and Stressor Related Disorders · Mental Disorder	Ohio State University PHASE2	Completed Registry updated 2026-10-16	12 ACTUAL	2023-01-01 2025-12-31 2026-07-31
Psilocybin Treatment in Obsessive-Compulsive Disorder: a Preliminary Efficacy Study and Exploratory Investigation of Neural Correlates. NCT03356483 Obsessive-Compulsive Disorder	Yale University PHASE1	Completed Registry updated 2026-10-16	28 ACTUAL	2018-11-13 2024-07-25 2024-07-25	Posted registry results
Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study NCT07391332 Gambling Disorder	Nantes University Hospital PHASE2	Recruiting Registry updated 2026-10-16	30 ESTIMATED	2026-10-08 2029-07-08 2029-07-08
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial NCT07820033 Advanced Cancer · Stage IV Solid Tumor Cancer · Stage IV Sarcoma of Bone · Stage IV Lymphoma · Stage IV Melanoma · Endocrine Cancer	University Health Network, Toronto PHASE2	Not yet recruiting Registry updated 2026-10-15	46 ESTIMATED	2026-09-14 2028-12-30 2029-07-30
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer NCT05398484 Advanced Cancer	NYU Langone Health PHASE2, PHASE3	Recruiting Registry updated 2026-10-14	200 ESTIMATED	2023-05-24 2027-01-01 2027-01-01
An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life NCT07719088 Aging · Longevity · Biomarkers of Aging	Charles Raison PHASE1	Not yet recruiting Registry updated 2026-10-13	50 ESTIMATED	2026-12 2028-04 2028-12
Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain NCT05224336 Phantom Limb Pain	University of California, San Diego PHASE1	Active, not recruiting Registry updated 2026-10-09	10 ACTUAL	2022-10-03 2024-03-07 2031-04-30
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial NCT07296094 Alcohol Use Disorder	Brigham and Women's Hospital PHASE2	Not yet recruiting Registry updated 2026-10-09	36 ESTIMATED	2026-11-15 2029-12-01 2030-02
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation NCT07818564 Phase I	Brown University PHASE1	Recruiting Registry updated 2026-10-08	24 ESTIMATED	2026-11 2027-11 2027-11
Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial NCT06386003 Post Traumatic Stress Disorder · PTSD · Chronic PTSD	Unity Health Toronto PHASE2	Active, not recruiting Registry updated 2026-10-06	15 ESTIMATED	2026-06-01 2028-01 2028-06
Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive Impairment NCT06041152 Amnestic Mild Cognitive Impairment	Centre for Addiction and Mental Health PHASE2	Completed Registry updated 2026-10-05	10 ACTUAL	2023-11-27 2026-02-19 2026-02-19
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy NCT07227909 Psilocybin · Neuropathy	M.D. Anderson Cancer Center PHASE2	Not yet recruiting Registry updated 2026-10-05	83 ESTIMATED	2026-11-04 2029-01-31 2031-01-31
Open-label, Single-arm fMRI Study Evaluating the Effects of Psilocybin on Craving in Nicotine Dependence. NCT07852832 Nicotine Dependence	University of British Columbia PHASE2	Not yet recruiting Registry updated 2026-10-01	3 ESTIMATED	2027-01 2027-12 2028-01
PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment NCT07610135 Mood (Psychological Function) · Well Being · Mood · Healthy	Johns Hopkins University PHASE1, PHASE2	Recruiting Registry updated 2026-10-01	20 ESTIMATED	2026-10-30 2028-06 2028-12
The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD NCT07332143 PTSD	Emory University PHASE2	Recruiting Registry updated 2026-10-01	150 ESTIMATED	2026-06-08 2027-03 2027-03
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study NCT07360301 Well-Being, Psychological · Psychedelic Experiences	University of Wisconsin, Madison PHASE1	Not yet recruiting Registry updated 2026-09-29	120 ESTIMATED	2026-10 2028-02 2028-02
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease NCT07610369 Depression · Parkinson's Disease (PD)	Yale University PHASE2	Recruiting Registry updated 2026-09-28	40 ESTIMATED	2026-07-10 2030-07 2030-07
Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study NCT07449351 Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI	Yale University EARLY_PHASE1	Not yet recruiting Registry updated 2026-09-24	20 ESTIMATED	2026-10-01 2028-04-01 2028-04-01
Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial NCT06299319 Obsessive-Compulsive Disorder	Centre for Addiction and Mental Health PHASE1	Completed Registry updated 2026-09-24	10 ACTUAL	2024-09-01 2026-09-04 2026-09-04
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study NCT06988319 Chronic Pelvic Pain	Oregon Health and Science University PHASE1	Recruiting Registry updated 2026-09-23	15 ESTIMATED	2026-11-01 2027-12-31 2027-12-31
ADEPT: Augmenting DBT Effectiveness With Psilocybin-Assisted Therapy NCT07833761 Borderline Personality Disorder · Borderline Personality Pathology · Depressive Symptoms · Emotion Dysregulation · Suicidal Ideation	University of Minnesota PHASE1	Not yet recruiting Registry updated 2026-09-22	18 ESTIMATED	2026-12-01 2029-12-31 2030-12-31
Psilocybin in the Treatment of Methamphetamine Use Disorder NCT07774702 Methamphetamine Use Disorder	Peter Hendricks PHASE2	Not yet recruiting Registry updated 2026-09-21	42 ESTIMATED	2027-02-01 2032-02-01 2032-02-01
Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ) NCT07210112 Depression - Major Depressive Disorder · Treatment-resistant Depression (TRD)	Centre Hospitalier St Anne PHASE2	Recruiting Registry updated 2026-09-21	112 ESTIMATED	2026-06-30 2029-12-31 2030-06-30
A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults NCT07516405 Healthy Volunteer · Older Adults (65-85 Years)	University of Colorado, Denver PHASE1	Recruiting Registry updated 2026-09-16	40 ESTIMATED	2026-04-01 2028-03 2028-03
PRoMiSS: Psilocybin and the Role of Music in Set and Setting NCT07180108 Psilocybin · Music Intervention	Johns Hopkins University PHASE1	Recruiting Registry updated 2026-09-15	100 ESTIMATED	2025-08-12 2028-06 2028-08
Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia NCT07607938 Anhedonia · Emotional Blunting	NYU Langone Health PHASE1	Recruiting Registry updated 2026-09-15	90 ESTIMATED	2026-09 2030-08-01 2030-09-30
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial NCT06943573 Bipolar II Depression	Lakshmi N Yatham PHASE2	Recruiting Registry updated 2026-09-15	90 ESTIMATED	2026-06-15 2028-12 2028-12
A Phase 1b Study to Evaluate the Safety and Tolerability of MLS101 Treatment for Premenstrual Dysphoric Disorder (PMDD) NCT07818720 Premenstrual Dysphoric Disorder ( PMDD) · PMDD	MycoMedica Life Sciences PBC PHASE1	Not yet recruiting Registry updated 2026-09-14	32 ESTIMATED	2026-12 2027-09 2027-12
Psilocybin Administration With 5-HT1a Blockade NCT07565493 Psychedelic Effects in Healthy Volunteers	Johns Hopkins University EARLY_PHASE1	Recruiting Registry updated 2026-09-14	18 ESTIMATED	2026-08-12 2028-06-15 2028-06-15
TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy NCT06200155 Depression, Anxiety · Psilocybin-Assisted Psychotherapy · Advanced Cancer	M.D. Anderson Cancer Center PHASE2	Recruiting Registry updated 2026-09-11	48 ESTIMATED	2024-04-16 2026-12-31 2026-12-31
A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial NCT06615908 Persisting Symptoms After Concussion	University of Calgary PHASE1	Recruiting Registry updated 2026-09-09	40 ESTIMATED	2025-05-27 2027-06-30 2027-12-30
A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease NCT07386730 Anhedonia in Healthy Volunteers · Older Adults (50-90 Years)	Jennifer Mitchell PHASE1	Recruiting Registry updated 2026-09-09	80 ESTIMATED	2026-06-01 2030-02 2030-02
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence NCT06885996 Post Traumatic Stress Disorder PTSD · Intimate Partner Violence (IPV)	University of Calgary PHASE2	Not yet recruiting Registry updated 2026-09-08	76 ESTIMATED	2026-10-01 2028-08-01 2029-08-01
Effects of Psilocybin in Obsessive Compulsive Disorder NCT05546658 Obsessive-Compulsive Disorder	Johns Hopkins University EARLY_PHASE1	Active, not recruiting Registry updated 2026-09-04	35 ACTUAL	2022-11-28 2026-12-30 2027-09-12
Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease NCT04123314 Depressive Symptoms · Depression · Alzheimer Disease · Mild Cognitive Impairment	Johns Hopkins University EARLY_PHASE1	Recruiting Registry updated 2026-09-04	20 ESTIMATED	2021-03-24 2027-06-30 2027-09-30
Psilocybin and Affective Function in Chronic Lower Back Pain Depression NCT06355414 Chronic Low-back Pain · Depression	Johns Hopkins University PHASE1	Recruiting Registry updated 2026-09-04	40 ESTIMATED	2024-04-22 2026-12-30 2026-12-30
Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD) NCT06989957 Posttraumatic Stress Disorder	Johns Hopkins University PHASE1	Recruiting Registry updated 2026-09-04	40 ESTIMATED	2025-09-17 2028-08 2029-08
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission NCT06430541 Breast Cancer · Ovarian Cancer	University of Colorado, Denver PHASE1	Recruiting Registry updated 2026-09-04	20 ESTIMATED	2024-11-21 2026-12 2028-12
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study NCT04932434 Parkinson Disease · Depression · Anxiety	Joshua Woolley, MD, PhD PHASE2	Completed Registry updated 2026-09-03	12 ACTUAL	2021-08-15 2024-12-31 2024-12-31
High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite Trial NCT07791901 Advanced Cancer · Demoralization · Existential Distress · Psychological Distress	University of Calgary PHASE2	Not yet recruiting Registry updated 2026-09-02	60 ESTIMATED	2026-10-30 2027-12-20 2027-12-31
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder NCT06349083 Alcohol Use Disorder	NYU Langone Health PHASE2	Recruiting Registry updated 2026-09-02	200 ESTIMATED	2026-09-01 2030-05 2030-05
The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults NCT06768944 Investigating the Importance of the Subjective Psychedelic Experience	University of Calgary PHASE2	Recruiting Registry updated 2026-09-02	128 ESTIMATED	2026-05-15 2027-12 2028-01
Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)] NCT06814522 Burnout · Burnout, Healthcare Workers	University of California, San Diego PHASE1, PHASE2	Recruiting Registry updated 2026-09-02	30 ESTIMATED	2025-01-13 2028-06 2028-08
An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study NCT06225232 Cannabis Use Disorder, Moderate · Cannabis Use Disorder, Severe	McMaster University PHASE2	Active, not recruiting Registry updated 2026-08-31	16 ESTIMATED	2025-03-21 2026-12 2026-12
Psilocybin-Assisted Psychotherapy for Posttraumatic Stress Disorder in Military Veterans: A Pilot Feasibility Study NCT07792538 Posttraumatic Stress Disorder (PTSD)	ARQ National Psychotrauma Centre PHASE2	Not yet recruiting Registry updated 2026-08-28	12 ESTIMATED	2026-12 2028-12 2028-12
A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study NCT04959253 Treatment Resistant Depression	King's College London PHASE2	Completed Registry updated 2026-08-28	60 ACTUAL	2021-06-21 2024-12-18 2024-12-18
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial NCT07211438 Treatment-Resistant Depression	Centre for Addiction and Mental Health PHASE2	Recruiting Registry updated 2026-08-21	40 ESTIMATED	2026-07-03 2028-07 2029-01
An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal Cancers NCT05220046 Pancreas Cancer · Biliary Tract Cancer · Psychological Distress · Gastrointestinal Cancer	University of Nebraska PHASE1	Completed Registry updated 2026-08-19	18 ACTUAL	2023-04-10 2025-11-17 2025-11-17
The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults NCT07169747 Anorexia Nervosa	Region Skane PHASE2	Recruiting Registry updated 2026-08-14	40 ESTIMATED	2026-07-20 2027-10-01 2027-10-01
Safety for Home Administration of Microdose Psilocybin Use NCT06450210 Psychedelic Experiences	Johns Hopkins University PHASE1	Completed Registry updated 2026-08-14	17 ACTUAL	2024-12-06 2026-07-31 2026-07-31
Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study) NCT06692192 Psilocybin	University of Wisconsin, Madison PHASE1	Recruiting Registry updated 2026-08-13	60 ESTIMATED	2025-08-07 2027-12 2027-12
Processing Intergenerational Trauma With Psilocybin-Assisted Therapy NCT06899165 Psychological Stress · Depression · Anxiety	Rachel Yehuda PHASE2	Recruiting Registry updated 2026-08-13	100 ESTIMATED	2026-08-28 2029-05-31 2030-01-02
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder NCT06247839 Major Depressive Disorder	Sharmin Ghaznavi PHASE3	Recruiting Registry updated 2026-08-13	20 ESTIMATED	2024-09-10 2028-06-30 2028-06-30
PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD) NCT06853912 Alcohol Use Disorder (AUD) · PTSD	Nathan Brashares Sackett PHASE2	Active, not recruiting Registry updated 2026-08-13	40 ESTIMATED	2025-06-01 2026-11-01 2027-06-01
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors NCT06801041 Depression · Anxiety · Cancer	M.D. Anderson Cancer Center PHASE2	Recruiting Registry updated 2026-08-12	20 ESTIMATED	2025-05-23 2027-03-31 2029-03-31
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality NCT06706232 Bipolar II Disorder · Depression, Bipolar · Suicidality	The University of Texas Health Science Center, Houston PHASE2	Recruiting Registry updated 2026-08-12	10 ESTIMATED	2025-07-07 2027-08 2027-08
Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids NCT06827054 Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm	Roswell Park Cancer Institute PHASE2	Not yet recruiting Registry updated 2026-08-12	20 ESTIMATED	2026-09-15 2027-05-05 2027-05-05
A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder NCT06969170 Generalized Anxiety Disorder (GAD)	Claudio N Soares PHASE2	Recruiting Registry updated 2026-08-12	50 ESTIMATED	2025-05-16 2027-12-31 2028-12-30
Psilocybin Recovery Intervention for Stopping Methamphetamine Use NCT07756736 Methamphetamine Use Disorder · Human Immunodeficiency Virus (HIV)	Nicky Mehtani, MD, MPH PHASE2	Not yet recruiting Registry updated 2026-08-11	30 ESTIMATED	2026-11 2029-04 2029-06
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis NCT06656702 Amyotrophic Lateral Sclerosis	Johns Hopkins University EARLY_PHASE1	Recruiting Registry updated 2026-08-11	24 ESTIMATED	2025-04-09 2027-01-30 2027-07-01
An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study) NCT06512194 Depression	Charles Raison PHASE2	Recruiting Registry updated 2026-08-10	141 ESTIMATED	2025-05-13 2029-05 2029-05
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression NCT05711940 Treatment Resistant Depression	COMPASS Pathways PHASE3	Active, not recruiting Registry updated 2026-08-10	572 ACTUAL	2023-02-14 2025-11-13 2026-12
Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury NCT07251491 Spinal Cord Injury · Depression - Major Depressive Disorder · Veteran	James J. Peters Veterans Affairs Medical Center PHASE1, PHASE2	Recruiting Registry updated 2026-08-10	30 ESTIMATED	2026-08-06 2028-03-01 2028-03-01
A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression NCT05624268 Treatment Resistant Depression	COMPASS Pathways PHASE3	Completed Registry updated 2026-08-10	258 ACTUAL	2023-01-24 2025-05-28 2026-04-15
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study NCT06506019 Bipolar Depression	University Health Network, Toronto PHASE1	Active, not recruiting Registry updated 2026-08-10	30 ESTIMATED	2024-10-09 2026-09-01 2027-01-01
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease NCT06455293 Parkinson Disease · Depression	Joshua Woolley, MD, PhD PHASE2	Recruiting Registry updated 2026-08-07	60 ESTIMATED	2024-08-19 2027-06 2028-06
Open Label Psilocybin Brain Stimulation and Imaging Pilot Study NCT06835699 Healthy Volunteers	Johns Hopkins University PHASE1	Completed Registry updated 2026-08-07	10 ACTUAL	2025-04-18 2026-05-21 2026-05-21
Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder NCT07406828 Pain Management · Postoperative Pain	Trent Emerick PHASE1	Not yet recruiting Registry updated 2026-08-06	70 ESTIMATED	2027-12-31 2029-04 2029-08
An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy NCT06233344 Mental Health	University of Southern California PHASE2	Recruiting Registry updated 2026-08-06	40 ESTIMATED	2025-07-30 2027-08 2028-08
Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies NCT07745569 PTSD · PTSD - Post Traumatic Stress Disorder · Major Depression · Suicidality	University of New Mexico PHASE2	Not yet recruiting Registry updated 2026-08-04	150 ESTIMATED	2026-08-31 2030-06-30 2030-06-30
Psilocybin as a Treatment for Chronic Pain in Smokers NCT07118332 Smokers With Chronic Pain	Yale University EARLY_PHASE1	Recruiting Registry updated 2026-08-03	10 ESTIMATED	2026-07-06 2027-10-01 2027-12-01
Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression NCT07737990 Treatment-resistant Depression (TRD)	Joshua Rosenblat NA	Enrolling by invitation Registry updated 2026-07-30	65 ESTIMATED	2026-07-01 2029-12-31 2030-06-30
Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for Post-Traumatic Stress Disorder NCT07737054 Post-Traumatic Stress Disorder, PTSD	Tel-Aviv Sourasky Medical Center EARLY_PHASE1	Recruiting Registry updated 2026-07-30	13 ESTIMATED	2025-07-22 2026-12-01 2026-12-31
An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD NCT07275970 PTSD	Scottsdale Research Institute PHASE1	Active, not recruiting Registry updated 2026-07-29	24 ESTIMATED	2026-03-20 2026-07-30 2026-10-01
Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin. NCT07732166 Healthy Adults	Pontifícia Universidade Católica do Rio de Janeiro EARLY_PHASE1	Recruiting Registry updated 2026-07-28	100 ESTIMATED	2026-04-01 2027-08-01 2027-12-01
A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder. NCT07347405 Obsessive-Compulsive Disorder	Francisco A Moreno PHASE1	Recruiting Registry updated 2026-07-23	30 ESTIMATED	2026-05-18 2028-12-31 2029-01-31
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought NCT05301608 Healthy	Johns Hopkins University PHASE1, PHASE2	Recruiting Registry updated 2026-07-23	30 ESTIMATED	2022-03-03 2026-12-01 2027-01-01
Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND) NCT05723276 Functional Neurological Disorder	King's College London NA	Completed Registry updated 2026-07-23	20 ACTUAL	2024-02-14 2026-04-14 2026-07-07
A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin NCT07710027 Healthy Controls	Diamond Therapeutics Inc. PHASE1	Completed Registry updated 2026-07-17	56 ACTUAL	2021-10-19 2022-03-12 2023-03-12
Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial NCT06067737 Opioid Use Disorder	Johns Hopkins University PHASE2	Recruiting Registry updated 2026-07-17	90 ESTIMATED	2024-02-08 2028-07 2029-05
Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled Trial NCT07703722 Major Depressive Disorder · Post-Traumatic Stress Disorder (PTSD)	Khyber Medical University Peshawar PHASE3	Recruiting Registry updated 2026-07-14	60 ESTIMATED	2026-04-01 2027-10-22 2027-11-22
Mechanistic Studies of Psilocybin in Headache Disorders NCT06464367 Migraine	Yale University EARLY_PHASE1	Recruiting Registry updated 2026-07-13	50 ESTIMATED	2025-05-19 2027-12-31 2027-12-31
PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial NCT07063862 Psychological Distress	Bruyère Health Research Institute. PHASE3	Recruiting Registry updated 2026-07-10	120 ESTIMATED	2026-01-28 2027-08 2027-09
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial NCT04754061 Depression, Anxiety · Distress, Emotional	Ottawa Hospital Research Institute PHASE1, PHASE2	Active, not recruiting Registry updated 2026-07-10	20 ESTIMATED	2024-01-08 2026-10-01 2027-01-01
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain NCT05265546 Perception Disorders	University of California, Berkeley PHASE1	Recruiting Registry updated 2026-07-10	80 ESTIMATED	2024-03-08 2028-12-31 2028-12-31
The Effects of Psilocybin on Social Connectedness NCT07693153 Loneliness · Grief	Yale University PHASE1	Not yet recruiting Registry updated 2026-07-09	51 ESTIMATED	2026-08-31 2031-12-15 2031-12-15
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2) NCT06341426 Major Depressive Disorder · Depression · Treatment-Resistant Depression · Mood Disorders	University Health Network, Toronto PHASE2	Active, not recruiting Registry updated 2026-07-09	92 ESTIMATED	2024-02-05 2026-07-28 2026-12-28
Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects NCT06624137 OCD · Major Depressive Disorder (MDD) · Alcohol Use Disorder (AUD) · Healthy Volunteer · Migraine · PTSD · PTSD - Post Traumatic Stress Disorder · Addiction · Tobacco Use Disorder · Obsessive Compulsive Disorder (OCD) · Opioid Use Disorder	Yale University Phase not reported	Terminated Registry updated 2026-07-09	5 ACTUAL	2024-12-12 2026-06-14 2026-06-14
Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder NCT06810310 Opioid Use Disorder	University of Pennsylvania PHASE2	Recruiting Registry updated 2026-07-09	24 ESTIMATED	2025-12-22 2027-05-01 2027-05-01
Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation NCT04161066 Opioid Use Disorder	University of Wisconsin, Madison PHASE1	Recruiting Registry updated 2026-07-07	10 ESTIMATED	2021-01-13 2026-12 2026-12
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD) NCT06160284 Opioid Use Disorder	Yale University PHASE1	Recruiting Registry updated 2026-07-07	12 ESTIMATED	2025-05-28 2027-01 2027-01
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms NCT07638553 Alcohol Use Disorder · Depressive Sympotoms · Psilocybin	Centre Hospitalier Universitaire de Nīmes PHASE3	Recruiting Registry updated 2026-07-01	172 ESTIMATED	2026-06-30 2030-06 2030-06
A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD) NCT06902974 Post Traumatic Stress Disorder · PTSD	Sunstone Medical PHASE2	Recruiting Registry updated 2026-07-01	70 ESTIMATED	2026-05-23 2027-11 2028-05
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder NCT05452772 Tobacco Use Disorder	Johns Hopkins University PHASE2	Recruiting Registry updated 2026-06-29	66 ESTIMATED	2023-11-01 2026-12 2027-05
Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects NCT06884514 Healthy	University Hospital, Basel, Switzerland PHASE1	Completed Registry updated 2026-06-25	24 ACTUAL	2025-04-03 2026-05-13 2026-05-28
Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial NCT07048743 Caregiver Distress	University Health Network, Toronto PHASE2	Recruiting Registry updated 2026-06-23	15 ESTIMATED	2025-07-16 2027-12-02 2027-12-02
Psilocybin-Assisted Therapy for Prolonged Grief NCT06724289 Prolonged Grief Disorder	University of Virginia EARLY_PHASE1	Recruiting Registry updated 2026-06-23	12 ESTIMATED	2026-03-24 2027-08 2027-08
Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy NCT06407635 Post Traumatic Stress Disorder	Johns Hopkins University PHASE1	Active, not recruiting Registry updated 2026-06-22	20 ESTIMATED	2024-06-07 2026-03-09 2027-05
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial NCT06416085 Advanced Cancer · Stage IV Solid Tumor Cancer · Stage IV Sarcoma of Bone · Stage IV Lymphoma · Stage IV Melanoma · Endocrine Cancer	University Health Network, Toronto PHASE2	Active, not recruiting Registry updated 2026-06-22	15 ESTIMATED	2024-06-06 2026-12-15 2026-12-15
The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function NCT07079852 Healthy	Manoj Doss PHASE1, PHASE2	Not yet recruiting Registry updated 2026-06-15	48 ESTIMATED	2026-09 2028-08 2028-08
Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-sampling NCT05698511 Psychedelic Experiences · Neuroimaging · Healthy Volunteers	Robin Carhart-Harris, PhD, MA PHASE1	Active, not recruiting Registry updated 2026-06-05	12 ESTIMATED	2023-07-31 2026-01-30 2027-01-30
Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study NCT05370911 Obsessive-Compulsive Disorder	Yale University PHASE1	Active, not recruiting Registry updated 2026-06-04	28 ACTUAL	2023-07-20 2026-02-17 2027-02
2 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy Volunteers NCT06626139 Healthy Participants With Lower-than-average Mental Well-being	Robin Carhart-Harris, PhD, MA PHASE2	Recruiting Registry updated 2026-06-04	120 ESTIMATED	2024-10-20 2027-11-30 2028-11-30
Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial NCT06230757 Major Depressive Disorder · Anhedonia · Treatment Resistant Depression	University of Colorado, Denver PHASE2	Completed Registry updated 2026-05-22	20 ACTUAL	2024-07-08 2026-05-08 2026-05-08
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder NCT07506395 PTSD	University of New Mexico PHASE1	Recruiting Registry updated 2026-05-22	36 ESTIMATED	2026-05-01 2027-05-01 2028-05-01
A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression NCT07582120 Depression	Washington University School of Medicine PHASE2	Not yet recruiting Registry updated 2026-05-20	50 ESTIMATED	2026-06 2031-06 2031-12
Psilocybin-assisted Cognitive Behavioral Therapy for Depression NCT05227612 Major Depressive Disorder	University of California, Los Angeles PHASE1	Completed Registry updated 2026-05-19	16 ACTUAL	2023-06-27 2025-09-12 2025-09-12
Psilocybin-facilitated Treatment for Cocaine Use NCT02037126 Cocaine-Related Disorders	University of Alabama at Birmingham PHASE2	Completed Registry updated 2026-05-18	40 ACTUAL	2015-05 2024-05 2024-05
Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY) NCT07216404 Lung Non-Small Cell Carcinoma · Unipolar Depression	Alan Davis PHASE2	Recruiting Registry updated 2026-05-14	10 ESTIMATED	2026-01-01 2027-10-31 2027-10-31
Psilocybin for Treatment of Obsessive Compulsive Disorder NCT06992999 Obsessive - Compulsive Disorder	Francisco A Moreno PHASE1, PHASE2	Not yet recruiting Registry updated 2026-05-12	20 ESTIMATED	2026-09-08 2028-12 2028-12
Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample NCT05322954 Methamphetamine Use Disorder · Substance-Related Disorders · Chemically-Induced Disorders · Substance Use Disorders · Stimulant-Use Disorder	University of Wisconsin, Madison PHASE1	Terminated Registry updated 2026-05-12	5 ACTUAL	2023-03-03 2024-03-07 2024-03-07
The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD. NCT06782724 COPD (Chronic Obstructive Pulmonary Disease) · ALS (Amyotrophic Lateral Sclerosis) · MS (Multiple Sclerosis) · Major Depressive Disorder (MDD) · Atypical Parkinson Disease	University Medical Center Groningen PHASE2	Recruiting Registry updated 2026-05-08	108 ESTIMATED	2025-07-01 2027-01-01 2028-01-01
Does Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial NCT05710237 Treatment-resistant Depression	Centre for Addiction and Mental Health PHASE2	Completed Registry updated 2026-05-07	41 ACTUAL	2023-07-01 2026-04-14 2026-04-14
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer NCT05947383 Cancer · Major Depressive Disorder	Sunstone Medical PHASE2	Active, not recruiting Registry updated 2026-05-06	56 ESTIMATED	2023-10-23 2027-04-30 2027-11-01
Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study NCT06303739 Refractory Depression · Treatment Resistant Depression	University of North Carolina, Chapel Hill PHASE3	Active, not recruiting Registry updated 2026-05-06	20 ACTUAL	2024-04-19 2026-04-09 2027-03-26
A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder NCT07479550 Major Depression	Stanford University PHASE2	Not yet recruiting Registry updated 2026-05-06	10 ESTIMATED	2026-07 2027-07 2027-08
A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control NCT04353921 Major Depressive Disorder	Usona Institute Phase not reported	Terminated Registry updated 2026-05-04	26 ACTUAL	2020-06-30 2022-10-18 2022-10-18
A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression NCT07565909 Depression · Anxiety	University of Washington PHASE2	Not yet recruiting Registry updated 2026-05-04	72 ESTIMATED	2026-06 2027-12 2028-07
Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder NCT07566104 Depression - Major Depressive Disorder · Psilocybin · Cognitive Behavioral Therapy	University of California, Los Angeles PHASE2	Not yet recruiting Registry updated 2026-05-04	30 ESTIMATED	2027-01 2028-12 2028-12
Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study) NCT05883540 Palliative Care · Pain · Anxiety · Depression · Demoralization · Psychological Distress · Quality of Life · Caregiver Burden · Fear of Death · Existential Distress	University Hospital, Basel, Switzerland PHASE2	Recruiting Registry updated 2026-04-29	60 ESTIMATED	2024-06-09 2027-09 2028-05
A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain NCT05351541 Chronic Low-back Pain	Joshua Woolley, MD, PhD PHASE1, PHASE2	Active, not recruiting Registry updated 2026-04-29	30 ESTIMATED	2023-12-01 2026-07 2026-09
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder NCT04982796 Amphetamine-Related Disorders	Portland VA Research Foundation, Inc PHASE1, PHASE2	Active, not recruiting Registry updated 2026-04-22	30 ESTIMATED	2022-07-07 2026-12-31 2026-12-31
A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD) NCT03866174 Depressive Disorder, Major	Usona Institute PHASE2	Completed Registry updated 2026-04-22	347 ACTUAL	2020-01-23 2022-06-28 2022-06-28	Evidence-guide report · Raison et al. · 2023
Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy NCT07373535 Treatment-Resistant Major Depressive Disorder	Kyle Greenway PHASE2	Not yet recruiting Registry updated 2026-04-22	16 ESTIMATED	2026-05 2028-07 2028-12
CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial NCT06319378 MDD	Section for Affective Disorders; Northern Stockholm Psychiatry PHASE2	Recruiting Registry updated 2026-04-13	100 ESTIMATED	2024-04-19 2026-12 2026-12
Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use Disorder NCT06102434 Cocaine Use Disorder	University of California, Los Angeles EARLY_PHASE1	Suspended Registry updated 2026-04-07	10 ESTIMATED	2029-02-01 2029-05 2029-06
Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy Participants NCT06180759 Healthy	University Hospital, Basel, Switzerland PHASE1	Completed Registry updated 2026-04-02	17 ACTUAL	2025-01-23 2025-09-29 2025-11-06
Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression NCT06072898 Depressive Disorder · Major Depressive Disorder	Sunnybrook Health Sciences Centre PHASE2	Recruiting Registry updated 2026-03-30	50 ESTIMATED	2025-05-28 2028-05 2029-05
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression NCT06898606 Depressive Disorder	Federal University of Latin American Integration PHASE1, PHASE2	Recruiting Registry updated 2026-03-27	24 ESTIMATED	2024-09-05 2026-08-20 2026-11-20
The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial. NCT05416229 Alcohol Use Disorder	Anders Fink-Jensen, MD, DMSci PHASE2	Completed Registry updated 2026-03-24	60 ACTUAL	2023-09-01 2025-12-22 2025-12-22
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial NCT07490353 Depression - Major Depressive Disorder · Anhedonia	Medical University of Vienna PHASE1	Recruiting Registry updated 2026-03-24	85 ESTIMATED	2025-11-01 2028-05-31 2028-05-31
Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies NCT07484906 Suicidal Ideation	University of New Mexico PHASE2	Withdrawn Registry updated 2026-03-20	0 ACTUAL	2026-05-01 2029-08-31 2029-08-31
Pilot Study of Psilocybin-assisted Treatment for Cannabis Use Disorder NCT06660381 Cannabis Use Disorder	Johns Hopkins University PHASE1	Recruiting Registry updated 2026-03-18	12 ESTIMATED	2024-11-08 2026-11 2026-12
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study NCT06818994 Demoralization · Safety	Gustavo Vazquez PHASE1	Recruiting Registry updated 2026-03-18	15 ESTIMATED	2026-04-01 2027-06-01 2027-06-01
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder NCT04620759 Major Depressive Disorder · Alcohol Use Disorder	Johns Hopkins University PHASE2	Active, not recruiting Registry updated 2026-03-13	90 ESTIMATED	2021-04-14 2026-03-02 2027-03-30
Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional Health NCT05227742 Demoralization	University of Alabama at Birmingham EARLY_PHASE1	Withdrawn Registry updated 2026-03-11	0 ACTUAL	2023-08-15 2026-03 2026-03
Psilocybin-facilitated Treatment for Chronic Pain NCT05068791 Fibromyalgia, Primary	University of Alabama at Birmingham EARLY_PHASE1	Recruiting Registry updated 2026-03-11	30 ESTIMATED	2023-11-01 2026-12-31 2026-12-31
Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study NCT06442423 Transdiagnostic · Depression - Major Depressive Disorder · Anxiety · PTSD Symptoms · PTSD · Substance Use · Substance Use Disorder (SUD) · OCD	Yale University PHASE1	Recruiting Registry updated 2026-03-11	50 ESTIMATED	2024-10-17 2027-12 2027-12
Pilot Proof of Concept Study Evaluating the Potential Psilocybin Assisted Psychotherapy (PAP) as a Therapeutic Tool for Patients Suffering From Severe Irritable Bowel Syndrome. NCT06760533 IBS - Irritable Bowel Syndrome	NYU Langone Health EARLY_PHASE1	Not yet recruiting Registry updated 2026-03-05	10 ESTIMATED	2026-08 2026-12 2026-12
Study of Psilocybin for Anorexia in Young Adults NCT06399263 Anorexia Nervosa	Marissa Raymond-Flesch, MD, MPH PHASE2	Recruiting Registry updated 2026-03-03	40 ESTIMATED	2024-11-18 2029-11 2029-11
The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers. NCT07433452 Healthy Participants · Placebo - Control · Psilocybin	Gabriella Gobbi PHASE1	Not yet recruiting Registry updated 2026-02-25	50 ESTIMATED	2026-09-01 2028-09-01 2029-09-01
Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial NCT06005662 Opioid Use Disorder	Johns Hopkins University PHASE2	Withdrawn Registry updated 2026-02-23	0 ACTUAL	2027-04 2028-07 2028-07
Investigation of Psychedelic Effects in Psychoactive Substances NCT06772753 Psychedelic Effects in Healthy Volunteers	Johns Hopkins University PHASE1	Recruiting Registry updated 2026-02-23	50 ESTIMATED	2025-02-05 2027-06 2027-12
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study NCT04950608 Hospice · Psilocybin · Demoralization · Terminal Illness · Cancer-related Problem/Condition · Psychotherapy · Terminal Cancer · Cancer Terminal	Yvan Beaussant, MD, MSci PHASE2	Completed Registry updated 2026-02-17	15 ACTUAL	2022-03-09 2024-07-27 2025-12-31
A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers NCT07050368 Healthy Volunteer	MycoMedica Life Sciences PBC PHASE1	Completed Registry updated 2026-02-13	20 ACTUAL	2025-07-28 2026-01-13 2026-01-13
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability NCT07053917 Stroke · Chronic Stroke · Intracerebral Haemorrhage · Intracerebral Haemorrhage (ICH) · Intracerebral Hemorrhage Basal Ganglia · Ischemic Stroke · Ischemic Stroke and Hemorrhagic Stroke · Hemiparesis After Stroke · Hemiplegia Following Ischemic Stroke · Hemiplegia and Hemiparesis · Hemiplegia and/or Hemiparesis Following Stroke · Middle Cerebral Artery Stroke	Johns Hopkins University PHASE1	Recruiting Registry updated 2026-02-13	20 ESTIMATED	2026-02-09 2027-02 2027-03
Psilocybin-Assisted Cognitive Behavioral Therapy for Depression NCT07281352 Major Depressive Diorder	University of California, Los Angeles PHASE1, PHASE2	Recruiting Registry updated 2026-02-12	50 ESTIMATED	2026-01-05 2027-11-30 2027-11-30
Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers NCT07079930 Healthy Volunteers	Hadassah Medical Organization PHASE1	Recruiting Registry updated 2026-02-05	10 ESTIMATED	2025-12-11 2026-11 2027-02
A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design NCT06206265 Irritable Bowel Syndrome	TRYP Therapeutics PHASE2	Active, not recruiting Registry updated 2026-02-05	14 ACTUAL	2024-01-17 2026-03-01 2026-03-01
A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment NCT06796062 Opioid Use Disorder	NYU Langone Health PHASE2	Recruiting Registry updated 2026-01-23	480 ESTIMATED	2025-12-17 2029-02 2029-02
The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma NCT06888128 PTSD	Baylor College of Medicine PHASE2	Recruiting Registry updated 2026-01-22	15 ESTIMATED	2025-01-30 2026-12-15 2026-12-15
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation NCT05220410 Treatment Resistant Depression · Suicidal Ideation	Sheppard Pratt Health System PHASE2	Completed Registry updated 2025-12-24	20 ACTUAL	2022-03-28 2025-05-12 2025-05-12
Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter NCT07296328 Stuttering	NYU Langone Health PHASE2	Not yet recruiting Registry updated 2025-12-22	25 ESTIMATED	2026-01-15 2027-04-01 2027-04-01
Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study NCT06798636 Self Harm	Imperial College London EARLY_PHASE1	Recruiting Registry updated 2025-12-05	30 ESTIMATED	2025-10-01 2026-08-31 2026-10-31
Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study NCT05585229 Opioid Dependence · Chronic Pain	University of British Columbia PHASE2	Recruiting Registry updated 2025-12-04	10 ESTIMATED	2025-10-27 2026-08-31 2026-08-31
Psilocybin vs Ketamine for Alcohol Use Disorder NCT06405607 Alcohol Use Disorder · Alcohol Dependence · Alcohol Abuse	University of Iowa PHASE2	Recruiting Registry updated 2025-11-28	80 ESTIMATED	2025-06-12 2028-04 2028-04
Digital Intervention for Psychedelic Preparation (DIPP): A Randomised Controlled Feasibility Trial Comparing Meditation and Music-Based Programs in Healthy Volunteers. NCT06815653 Healthy	University College, London PHASE1	Recruiting Registry updated 2025-11-26	40 ESTIMATED	2025-03-01 2026-03 2026-12
Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder NCT06132178 Treatment Resistant Depression · MDD · Major Depressive Disorder · Recurrent Depression · Depression	University of Texas at Austin PHASE2	Recruiting Registry updated 2025-11-26	100 ESTIMATED	2025-01-10 2029-12-31 2030-12-31
Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life NCT05403086 Demoralization	Charles S. Grob, M.D. PHASE2	Recruiting Registry updated 2025-11-25	100 ESTIMATED	2025-01-19 2026-12-31 2027-12-31
Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans NCT06081179 Healthy	University of Zurich PHASE1	Completed Registry updated 2025-11-19	122 ACTUAL	2023-10-24 2025-09-22 2025-09-22
A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression NCT07183748 Treatment Resistant Depression	Beersheva Mental Health Center PHASE2	Recruiting Registry updated 2025-11-19	20 ESTIMATED	2025-12-01 2027-06-01 2028-06-01
Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients. NCT04882839 Obsessive-compulsive Disorder	Beersheva Mental Health Center PHASE2	Recruiting Registry updated 2025-11-19	15 ESTIMATED	2024-11-25 2026-06-01 2027-06-01
Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder NCT05421065 Alcohol Use Disorder	Peggy C Nopoulos PHASE2	Active, not recruiting Registry updated 2025-11-17	20 ESTIMATED	2024-02-02 2025-08-30 2026-09
Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder NCT03554174 Major Depressive Disorder	Yale University PHASE1	Active, not recruiting Registry updated 2025-11-05	18 ESTIMATED	2018-02-27 2021-07-08 2026-09
A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer NCT05847686 Hematopoietic and Lymphatic System Neoplasm · Metastatic Malignant Solid Neoplasm	University of Washington PHASE1, PHASE2	Completed Registry updated 2025-11-05	55 ACTUAL	2023-06-27 2024-04-08 2024-10-17
Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin NCT04501653 Psilocybin	Washington University School of Medicine EARLY_PHASE1	Completed Registry updated 2025-10-31	11 ACTUAL	2021-06-01 2023-03-19 2023-03-19
A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)? NCT06786325 Opioid Use Disorder	Anna Rose Childress, Ph.D. PHASE2	Recruiting Registry updated 2025-10-29	36 ESTIMATED	2025-10-07 2027-06 2027-10
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults NCT06367738 Aging	University of California, Berkeley PHASE1	Recruiting Registry updated 2025-10-21	40 ESTIMATED	2025-11 2026-12-30 2027-12-30
A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer NCT06644170 Hematopoietic and Lymphatic System Neoplasm · Metastatic Malignant Solid Neoplasm	University of Washington PHASE1	Completed Registry updated 2025-10-14	15 ACTUAL	2024-11-19 2025-09-30 2025-09-30
A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine NCT06899594 Methamphetamine Use Disorder	Kevin Murnane EARLY_PHASE1	Recruiting Registry updated 2025-10-07	20 ESTIMATED	2025-04-04 2027-03 2027-03
Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment NCT07164287 Major Depressive Disorder (MDD) · Anxiety Disorders · Substance Use Disorder (SUD) · PTSD - Post Traumatic Stress Disorder	University Hospital, Geneva Phase not reported	Active, not recruiting Registry updated 2025-10-02	376 ESTIMATED	2020-06-01 2025-04-30 2025-09-30
Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism NCT07189988 Alcohol Use Disorder	Healing Advocacy Fund Phase not reported	Active, not recruiting Registry updated 2025-09-24	20 ACTUAL	2025-03-05 2026-06-10 2026-08-05
The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial. NCT06368492 Fibromyalgia	Maastricht University NA	Recruiting Registry updated 2025-09-15	35 ESTIMATED	2024-05-03 2025-12 2025-12
Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression. NCT07164755 Depression - Major Depressive Disorder	King's College London Phase not reported	Active, not recruiting Registry updated 2025-09-10	46 ACTUAL	2021-06-21 2026-09 2026-09
Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial NCT06746441 Major Depressive Disorder	Khyber Medical University Peshawar PHASE2	Completed Registry updated 2025-09-02	60 ACTUAL	2024-12-01 2025-06-01 2025-07-30
Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic Seizures NCT06647056 Psychogenic Nonepileptic Seizures · Psilocybin	Centre Hospitalier Universitaire de Nīmes NA	Completed Registry updated 2025-08-21	4 ACTUAL	2024-12-19 2025-01-03 2025-05-22
Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study NCT06650800 Depressive Disorder · Depressive Disorder, Treatment-Resistant · Hallucinogens · Reinforcement, Psychology	Centre Hospitalier Universitaire de Nīmes NA	Completed Registry updated 2025-08-20	10 ACTUAL	2024-11-19 2025-03-26 2025-06-26
Effects of Psilocybin in Post-Treatment Lyme Disease NCT05305105 Post-Treatment Lyme Disease · Chronic Lyme Disease · Lyme Disease, Chronic	Johns Hopkins University PHASE1	Completed Registry updated 2025-08-20	20 ACTUAL	2022-07-01 2024-10-26 2025-04-07
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder NCT05733546 Major Depressive Disorder	COMPASS Pathways PHASE2	Active, not recruiting Registry updated 2025-08-19	102 ACTUAL	2023-01-30 2025-09 2025-09
Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD) NCT05651126 Autism Spectrum Disorder	King's College London NA	Completed Registry updated 2025-07-28	67 ACTUAL	2022-12-12 2024-08-23 2024-08-23
The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC) NCT05506982 Hematopoietic and Lymphoid Cell Neoplasm · Malignant Solid Neoplasm	Emory University PHASE1	Completed Registry updated 2025-07-23	11 ACTUAL	2022-11-01 2024-04-25 2025-01-24
Visual Surround Suppression and Perceptual Expectation Under Psilocybin NCT04424225 Perception Disturbance · Visual Suppression · Psychedelic Experiences	University of Minnesota PHASE1	Terminated Registry updated 2025-06-27	10 ACTUAL	2021-08-30 2023-09-01 2023-09-01
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder NCT05312151 Post Traumatic Stress Disorder	COMPASS Pathways PHASE2	Completed Registry updated 2025-06-13	22 ACTUAL	2022-06-10 2024-02-12 2024-02-12
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants NCT06643637 Healthy Volunteers	MycoMedica Life Sciences PBC PHASE1	Completed Registry updated 2025-06-12	16 ACTUAL	2024-11-08 2025-03-12 2025-03-12
Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy Adults NCT05317689 Healthy	University of California, San Francisco PHASE1	Active, not recruiting Registry updated 2025-06-10	20 ESTIMATED	2022-05-26 2025-01-16 2025-07
Psilocybin With Intracranial Neural Sensing NCT06919640 Chronic Pain	Joshua Woolley, MD, PhD PHASE1	Enrolling by invitation Registry updated 2025-06-06	20 ESTIMATED	2025-06-01 2028-04-30 2028-04-30
Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study NCT06372197 Depression	Matthew Hicks NA	Completed Registry updated 2025-06-05	20 ACTUAL	2024-08-01 2025-05-14 2025-05-14
Optimizing Microdosing and Meditation NCT06560658 Meditation · Microdosing	National University of Natural Medicine NA	Withdrawn Registry updated 2025-06-05	0 ACTUAL	2024-10-01 2025-10-01 2025-11-01
Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study) NCT06796361 Healthy	University Hospital, Basel, Switzerland PHASE1	Recruiting Registry updated 2025-05-28	16 ESTIMATED	2025-04-21 2026-08 2026-08
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study NCT01943994 Nicotine Dependence	Johns Hopkins University NA	Completed Registry updated 2025-05-25	82 ACTUAL	2008-09 2023-05-01 2023-11-14	Evidence-guide report · Johnson et al. · 2026 randomized pilot
Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase NCT05592379 Healthy · Psychedelic Experiences · Sleep	University of Wisconsin, Madison PHASE1	Completed Registry updated 2025-05-16	6 ACTUAL	2023-11-07 2025-02-19 2025-02-19
Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder NCT06592833 Major Depressive Disorder	Icahn School of Medicine at Mount Sinai PHASE2	Recruiting Registry updated 2025-05-14	60 ESTIMATED	2025-02-25 2028-03-01 2028-03-01
A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia NCT05128162 Fibromyalgia	Kevin Boehnke PHASE2	Completed Registry updated 2025-04-16	17 ACTUAL	2023-09-27 2024-06-12 2024-06-12
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training NCT05570708 Personal Experience of Substance-assisted Therapy Using Psilocybin, MDMA, and LSD	Felix Mueller NA	Enrolling by invitation Registry updated 2025-04-14	48 ESTIMATED	2022-10-25 2029-06-01 2029-06-01
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects: A Placebo-controlled Cross-over Study (DMT BDR-Study). NCT05695495 Healthy	University Hospital, Basel, Switzerland PHASE1	Completed Registry updated 2025-04-11	36 ACTUAL	2024-06-12 2025-02-02 2025-03-04
Psilocybin-assisted Interpersonal Therapy for Depression NCT05581797 Depressive Disorder, Treatment-Resistant	University of Otago NA	Completed Registry updated 2025-04-09	5 ACTUAL	2023-03-15 2024-05-06 2024-06-04
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN NCT06731335 Chronic Neuropathic Pain · Pain Management	Unity Health Toronto PHASE2	Recruiting Registry updated 2025-03-30	30 ESTIMATED	2025-03-05 2026-08 2026-12
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study) NCT06899334 Healthy	University Hospital, Basel, Switzerland PHASE1	Recruiting Registry updated 2025-03-27	24 ESTIMATED	2025-04-01 2026-08-01 2026-08-01
Molecular Imaging Study of Harmine/DMT: a Basic Research Approach NCT06252506 Neuropharmacological Investigation of Ayahuasca Constituents DMT and Harmine	Insel Gruppe AG, University Hospital Bern PHASE1	Completed Registry updated 2025-03-19	17 ACTUAL	2024-01-22 2025-02-17 2025-03-05
Psilocybin in Alcohol Use Disorder With Comorbid Depression NCT06235411 Alcohol-Related Disorders · Depressive Disorder · Addiction	Centre Hospitalier Universitaire de Nīmes NA	Completed Registry updated 2025-03-19	30 ACTUAL	2024-02-05 2024-11-19 2025-01-09
A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout NCT05163496 Burnout, Caregiver · Burnout, Professional · COVID-19 · Depression · Post Traumatic Stress Disorder · Moral Injury	University of Washington PHASE3	Completed Registry updated 2025-03-18	30 ACTUAL	2022-03-03 2023-12-30 2024-06-30
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety NCT00302744 Anxiety	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center PHASE1, PHASE2	Completed Registry updated 2025-03-13	12 ACTUAL	2004-04 2008-12 2008-12
Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects NCT05523401 Healthy	University Hospital, Basel, Switzerland PHASE1	Completed Registry updated 2025-03-05	24 ACTUAL	2023-08-16 2024-10-20 2024-11-05
A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression NCT04670081 Treatment-resistant Depression	Central Institute of Mental Health, Mannheim PHASE2	Completed Registry updated 2025-01-20	144 ACTUAL	2021-06-10 2024-02-27 2024-12-11	Evidence-guide report · Mertens et al. · EPISODE · 2026
The Neurobiological Effect of 5-HT2AR Modulation NCT03289949 Basic Science	Gitte Moos Knudsen PHASE1	Recruiting Registry updated 2024-12-16	200 ESTIMATED	2017-03-03 2030-06-01 2030-06-01
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study NCT05481736 Anorexia Nervosa	COMPASS Pathways PHASE2	Completed Registry updated 2024-12-04	32 ACTUAL	2022-10-12 2024-11-18 2024-11-18
A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder NCT05035927 Binge Eating Disorder	TRYP Therapeutics PHASE2	Completed Registry updated 2024-11-19	5 ACTUAL	2022-03-16 2024-03-07 2024-06-07
PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout NCT05557643 Depression · Burnout, Professional	University of Utah PHASE1	Completed Registry updated 2024-11-12	24 ACTUAL	2023-01-02 2024-09-20 2024-09-20
PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study) NCT06258031 Obsessive-Compulsive Disorder	Imperial College London PHASE1	Completed Registry updated 2024-11-06	19 ACTUAL	2022-10-28 2024-06-28 2024-07-24
A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study NCT06666010 Stimulant Use Disorder	Filament Health Corp. PHASE2	Not yet recruiting Registry updated 2024-10-30	86 ESTIMATED	2025-01 2028-01 2028-07
Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms NCT03429075 Depressive Disorder, Major	Imperial College London PHASE2	Completed Registry updated 2024-10-24	59 ACTUAL	2019-01-07 2020-04-17 2020-10-17	Evidence-guide report · Carhart-Harris et al. · 2021
A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants NCT06326606 Healthy Volunteers	MycoMedica Life Sciences PBC PHASE1	Completed Registry updated 2024-10-09	24 ACTUAL	2024-03-27 2024-07-08 2024-07-08
The Effects of Psilocybin on Shared Experience in Film Processing NCT06529939 Disorders of Consciousness · Psychedelic Experiences	Western University, Canada NA	Unknown status Registry updated 2024-09-27	30 ESTIMATED	2024-11 2025-09 2025-09
An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder NCT05065294 Bipolar II Disorder	University of California, San Francisco PHASE2	Active, not recruiting Registry updated 2024-09-25	14 ESTIMATED	2022-01-28 2024-08-01 2025-07
Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus NCT06378229 Treatment Resistant Depression	University Hospital, Ghent PHASE2	Recruiting Registry updated 2024-09-19	100 ESTIMATED	2024-05-21 2026-03 2026-12-31
Psilocybin for Treatment of Obsessive Compulsive Disorder NCT03300947 Obsessive-compulsive Disorder (OCD)	University of Arizona PHASE1	Completed Registry updated 2024-08-30	15 ACTUAL	2019-01-02 2023-10-30 2023-12-30
A 24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD) NCT05646303 Alcohol Use Disorder	Clairvoyant Therapeutics PHASE2	Unknown status Registry updated 2024-08-15	128 ESTIMATED	2022-05-02 2024-08-31 2024-12-31
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) NCT04433858 Treatment Resistant Depression	Sheppard Pratt Health System PHASE2	Active, not recruiting Registry updated 2024-08-09	27 ACTUAL	2021-03-01 2025-06-01 2026-05-01
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms NCT06160232 Severe Alcohol Use Disorder	Brugmann University Hospital PHASE2	Recruiting Registry updated 2024-08-07	62 ESTIMATED	2024-02-15 2025-12-15 2026-06-15
Psilocybin for the Treatment of Major Depressive Disorder NCT05675800 Major Depressive Disorder	Washington University School of Medicine PHASE2	Withdrawn Registry updated 2024-07-25	0 ACTUAL	2024-01-01 2025-01-01 2025-03-31
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study NCT04718792 Alcohol Use Disorder (AUD)	Anders Fink-Jensen, MD, DMSci PHASE2	Unknown status Registry updated 2024-07-12	10 ACTUAL	2023-02-09 2024-07-21 2024-07-21
Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First Responders NCT06471959 Psilocybin · Psychotherapy, Group	Empower Research Inc PHASE1, PHASE2	Unknown status Registry updated 2024-06-24	32 ESTIMATED	2025-01-01 2025-07-01 2025-09-01
Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion NCT02243813 Healthy	Johns Hopkins University PHASE1	Completed Registry updated 2024-06-18	24 ACTUAL	2015-03 2024-05-31 2024-05-31
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study NCT04505189 Anorexia Nervosa	Imperial College London PHASE1, PHASE2	Completed Registry updated 2024-06-17	21 ACTUAL	2021-05-28 2023-12-11 2024-06-12
A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder NCT06444243 Alcohol Use Disorder · Alcohol Dependence · Depression · Anxiety	University of Sydney PHASE2	Unknown status Registry updated 2024-06-10	90 ESTIMATED	2024-09 2025-07 2025-12
An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients NCT05832255 Fragile X Syndrome · Behavior · Cognitive Dysfunction	Nova Mentis Life Science Corp PHASE2	Suspended Registry updated 2024-05-08	10 ESTIMATED	2023-03-28 2024-05 2024-05
Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial NCT05995769 Alcohol Use Disorder · Alcoholism	University of Calgary PHASE2	Recruiting Registry updated 2024-05-07	128 ESTIMATED	2024-03-20 2027-10-01 2027-10-01
Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study NCT05384678 Healthy	University Hospital, Basel, Switzerland PHASE1	Completed Registry updated 2024-04-25	24 ACTUAL	2022-11-15 2024-03-08 2024-03-13
The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study NCT04630964 Major Depressive Disorder · Depression	Section for Affective Disorders; Northern Stockholm Psychiatry PHASE2	Completed Registry updated 2024-04-19	35 ACTUAL	2021-01-01 2023-04-19 2024-04-18	Evidence-guide report · Yngwe et al. · Stockholm trial · 2026
A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer NCT04522804 Cancer	University of Utah EARLY_PHASE1	Completed Registry updated 2024-03-20	12 ACTUAL	2021-10-04 2022-06-11 2022-12-16
Repeat Dosing of Psilocybin in Headache Disorders NCT04218539 Migraine Headache	Yale University PHASE1	Completed Registry updated 2024-02-09	18 ACTUAL	2021-08-10 2023-11-05 2023-11-05
A Randomized, Double-Blind Study of Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use NCT05242029 Opioid Use Disorder	Johns Hopkins University PHASE2	Withdrawn Registry updated 2024-02-02	0 ACTUAL	2023-12 2024-02 2024-12
Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy Subjects NCT04227756 Healthy	University Hospital, Basel, Switzerland PHASE1	Completed Registry updated 2024-01-24	32 ACTUAL	2020-05-19 2022-09-02 2022-09-02
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD NCT05381974 Treatment-Resistant Major Depressive Disorder	Massachusetts General Hospital PHASE2	Withdrawn Registry updated 2024-01-24	0 ACTUAL	2022-09-15 2023-06-01 2023-06-01
Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action NCT05548075 Fibromyalgia	Imperial College London Phase not reported	Unknown status Registry updated 2024-01-19	20 ESTIMATED	2022-08-15 2024-01-10 2024-07-30
Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder NCT05562973 Post-Traumatic Stress Disorder	Johns Hopkins University PHASE1	Withdrawn Registry updated 2024-01-05	0 ACTUAL	2025-01 2025-12 2025-12
Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma. NCT00979693 Anxiety · Stage IV Melanoma	Multidisciplinary Association for Psychedelic Studies PHASE2	Withdrawn Registry updated 2023-12-26	0 ACTUAL	2012-01 2013-04 2013-06
Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders NCT02981173 Cluster Headache	Yale University PHASE1	Completed Registry updated 2023-12-15	25 ACTUAL	2016-12-05 2022-06-30 2022-10-21
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD). NCT06141876 Post-traumatic Stress Disorder · Depression	Apex Labs Ltd. PHASE2	Unknown status Registry updated 2023-11-29	160 ESTIMATED	2023-12-15 2025-06-15 2025-06-15
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression NCT04739865 Treatment Resistant Depression	COMPASS Pathways PHASE2	Completed Registry updated 2023-11-09	19 ACTUAL	2020-08-10 2021-10-14 2021-10-14
Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II NCT03806985 Post-Traumatic Headache	Yale University PHASE1	Terminated Registry updated 2023-10-12	12 ACTUAL	2019-03-28 2023-06-27 2023-06-27
Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I NCT03341689 Migraine Headache	Yale University PHASE1	Completed Registry updated 2023-10-12	14 ACTUAL	2017-11-01 2021-04-30 2021-10-31
Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence NCT01534494 Alcohol Dependence	University of New Mexico PHASE2	Completed Registry updated 2023-09-26	10 ACTUAL	2012-01 2013-09 2014-03
Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced Meditators NCT05780216 Healthy Participants	Milan Scheidegger EARLY_PHASE1	Completed Registry updated 2023-09-21	40 ACTUAL	2023-02-20 2023-08-05 2023-09-15
Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder NCT04141501 Alcohol Use Disorder	University of Zurich PHASE2	Completed Registry updated 2023-09-21	37 ACTUAL	2020-06-08 2023-03-14 2023-09-14	Evidence-guide report · Swiss relapse-prevention trial · 2025
Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions NCT06035900 Side Effect of Drug	Lobe Sciences Ltd. PHASE1	Completed Registry updated 2023-09-13	10 ACTUAL	2023-06-21 2023-07-30 2023-07-30
A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics NCT05478278 QTc Interval · Pharmacokinetics	Usona Institute PHASE1	Completed Registry updated 2023-08-15	60 ACTUAL	2022-06-22 2023-08-09 2023-08-09
The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study NCT05029466 Treatment Resistant Depression	Brain and Cognition Discovery Foundation PHASE2	Completed Registry updated 2023-07-27	30 ACTUAL	2021-11-19 2023-07-22 2023-07-22
An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients. NCT05958758 End of Life	The Roots to Thrive Society for Psychedelic Therapy EARLY_PHASE1	Unknown status Registry updated 2023-07-25	64 ESTIMATED	2023-09-01 2025-04-30 2025-10-31
Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD) NCT05594667 Depression · Major Depressive Disorder · Mild Depression · Moderate Depression · Depressive Disorder	Cybin Therapeutics Inc. PHASE2	Withdrawn Registry updated 2023-07-06	0 ACTUAL	2023-01-01 2023-03-14 2023-03-14
Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder NCT05243329 Treatment Resistant Disorders · Post Traumatic Stress Disorder	Halucenex Life Sciences Inc. PHASE2	Unknown status Registry updated 2023-06-29	20 ESTIMATED	2022-10-03 2023-10-30 2023-12-30
Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans NCT05876481 PTSD	Combat Stress PHASE2	Unknown status Registry updated 2023-05-25	8 ESTIMATED	2023-06 2025-07 2025-08
Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers NCT04842045 Psychedelic Experiences · Amnesia	University of Wisconsin, Madison PHASE1	Completed Registry updated 2023-05-19	8 ACTUAL	2021-05-21 2022-11-17 2022-11-17
A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin NCT05467761 Healthy	University of Wisconsin, Madison PHASE1	Withdrawn Registry updated 2023-05-15	0 ACTUAL	2023-06 2024-03 2024-03
Effects of Psilocybin in Anorexia Nervosa NCT04052568 Anorexia Nervosa	Johns Hopkins University PHASE1	Completed Registry updated 2023-05-06	22 ACTUAL	2019-08-26 2022-01-05 2023-04-20
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression NCT03775200 Treatment Resistant Depression	COMPASS Pathways PHASE2	Completed Registry updated 2023-04-24	233 ACTUAL	2019-03-01 2021-07-30 2021-09-27	Evidence-guide report · Goodwin et al. · COMP001 · 2022
Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness NCT04849013 Healthy	University Hospital, Basel, Switzerland PHASE1	Completed Registry updated 2023-03-29	16 ACTUAL	2021-08-11 2023-03-27 2023-03-27
Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study NCT05252598 Mood Disturbance · Mood Change · Sleep Disturbance · Drug Effect · Psychedelic Experiences · Health, Subjective · Psilocin Toxicity · Psilocybin Toxicity · Psilocybin Causing Adverse Effects in Therapeutic Use · Anxiety	Optimi Health Corporation EARLY_PHASE1	Withdrawn Registry updated 2023-03-20	0 ACTUAL	2023-01 2023-08 2023-12
Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder NCT04656301 Body Dysmorphic Disorders	New York State Psychiatric Institute PHASE2	Completed Registry updated 2023-03-13	12 ACTUAL	2021-02-26 2022-11-02 2022-11-02
SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression NCT05601648 Major Depressive Disorder · Anhedonia	Washington University School of Medicine PHASE2	Withdrawn Registry updated 2023-01-30	0 ACTUAL	2023-07-01 2025-01-01 2025-07-01
Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder NCT04410913 Alcohol Use Disorder	Keith Heinzerling PHASE2	Active, not recruiting Registry updated 2023-01-17	20 ACTUAL	2021-02-18 2023-02 2023-02
NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System. NCT05042466 Trauma, Nervous System	NWTraumatherapies PHASE1	Unknown status Registry updated 2022-11-16	30 ESTIMATED	2023-09-03 2025-08-30 2025-10-03
A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence NCT02061293 Alcohol Dependence	NYU Langone Health PHASE2	Completed Registry updated 2022-11-08	95 ACTUAL	2014-06 2021-07-30 2021-07-30	Evidence-guide report · Bogenschutz et al. · 2022
The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. NCT04433845 Treatment Resistant Depression	Sheppard Pratt Health System PHASE2	Unknown status Registry updated 2022-10-25	15 ACTUAL	2021-03-01 2023-01-15 2023-04-15
An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA) NCT04905121 Short Lasting Unilateral Neuralgiform Headache Attacks	Beckley Psytech Limited PHASE1	Terminated Registry updated 2022-10-12	4 ACTUAL	2021-08-11 2022-04-22 2022-04-22
Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU) NCT04519957 Treatment Resistant Depression	COMPASS Pathways Phase not reported	Completed Registry updated 2022-09-22	66 ACTUAL	2020-07-20 2022-08-11 2022-08-11
Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study NCT04280055 Cluster Headache	Gitte Moos Knudsen PHASE1, PHASE2	Terminated Registry updated 2022-08-10	10 ACTUAL	2020-01-21 2020-11-01 2022-06-01
Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy NCT04661514 Anorexia Nervosa	University of California, San Diego PHASE2	Completed Registry updated 2022-07-25	16 ACTUAL	2021-05-01 2022-03-10 2022-06-10
Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults NCT04989972 Anxiety and Depression	Wake Network, Inc. PHASE2	Withdrawn Registry updated 2022-06-30	0 ACTUAL	2022-09-15 2023-06-20 2023-08-31
Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression NCT05383313 Treatment Resistant Depression	National Institute of Mental Health, Czech Republic PHASE2	Unknown status Registry updated 2022-05-20	60 ESTIMATED	2021-05-01 2025-04-30 2025-04-30
Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression NCT03715127 Depressive Disorder, Major	University of Zurich PHASE2	Completed Registry updated 2022-04-29	55 ACTUAL	2019-03-11 2021-10-12 2022-04-12	Evidence-guide report · von Rotz et al. · 2023
A Randomized Controlled Trial of the Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion NCT02421263 Religious or Spiritual Problem	NYU Langone Health PHASE1	Completed Registry updated 2022-02-14	12 ACTUAL	2015-04 2020-06-05 2020-06-05
LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study NCT03153579 Patients · Anxiety Disorders	University Hospital, Basel, Switzerland PHASE2	Completed Registry updated 2021-12-22	46 ACTUAL	2017-06-23 2021-12-15 2021-12-15
Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health NCT05160220 Cognitive Change · Creativity · Mood Change · Sleep	National Council of Scientific and Technical Research, Argentina NA	Completed Registry updated 2021-12-16	34 ACTUAL	2021-01-20 2021-06-30 2021-10-01
Effects of Psilocybin in Major Depressive Disorder NCT03181529 Major Depressive Disorder	Johns Hopkins University PHASE2	Completed Registry updated 2021-12-15	27 ACTUAL	2017-08-10 2020-12-02 2020-12-02	Evidence-guide report · Davis et al. · 2021
The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder NCT04593563 Major Depressive Disorder	Maryland Oncology Hematology, PA PHASE2	Unknown status Registry updated 2021-10-15	30 ACTUAL	2020-09-01 2022-10 2023-10
Characterization of Altered Waking States of Consciousness in Healthy Humans NCT03853577 Altered Waking States of Consciousness in Healthy Humans	University of Zurich NA	Completed Registry updated 2021-04-29	25 ACTUAL	2020-07-08 2021-04-25 2021-04-25
Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin in a Random-order Placebo-controlled Cross-over Study in Healthy Subjects NCT03604744 Healthy	University Hospital, Basel, Switzerland EARLY_PHASE1	Completed Registry updated 2021-04-27	28 ACTUAL	2019-03-27 2021-04-10 2021-04-15
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors NCT02950467 Distress · Depression · Grief	Joshua Woolley PHASE1	Completed Registry updated 2021-01-07	30 ACTUAL	2018-01-05 2019-12-31 2019-12-31
Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects NCT03912974 Healthy	University Hospital, Basel, Switzerland PHASE1	Completed Registry updated 2020-12-01	27 ACTUAL	2019-07-04 2020-11-26 2020-11-26
Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self NCT03736980 Healthy	University of Zurich NA	Completed Registry updated 2020-11-04	140 ACTUAL	2013-10-01 2018-12-31 2018-12-31
Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients NCT00957359 Cancer	NYU Langone Health EARLY_PHASE1	Completed Registry updated 2020-10-20	29 ACTUAL	2009-02 2018-09-06 2018-09-06
Pharmacokinetics of Psilocybin in Normal Adult Volunteers NCT02163707 Healthy	University of Wisconsin, Madison PHASE1	Completed Registry updated 2020-04-15	12 ACTUAL	2014-06 2015-12 2015-12
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators NCT02145091 Healthy	Johns Hopkins University PHASE1	Completed Registry updated 2019-12-30	40 ACTUAL	2014-05 2019-12-26 2019-12-26
Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin NCT02971605 Healthy	Johns Hopkins University PHASE1, PHASE2	Completed Registry updated 2019-09-10	13 ACTUAL	2017-07-01 2018-08-21 2018-08-21
A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis. NCT03661125 Parkinson Disease Psychosis	King's College London EARLY_PHASE1	Unknown status Registry updated 2019-08-13	30 ESTIMATED	2019-04-11 2021-09-01 2021-09-01
Psychopharmacology of Psilocybin in Cancer Patients NCT00465595 Depressive Symptoms · Anxiety · Cancer	Johns Hopkins University PHASE2	Completed Registry updated 2018-07-19	56 ACTUAL	2007-04 2014-12 2016-12	Evidence-guide report · Griffiths et al. · 2016
Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression NCT03380442 Severe Depression	University of Helsinki PHASE2	Unknown status Registry updated 2017-12-21	60 ESTIMATED	2018-09 2020-01 2021-09
Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior NCT00802282 Healthy	Johns Hopkins University PHASE1	Completed Registry updated 2016-02-24	75 ACTUAL	2009-08 2014-02 2014-05
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators NCT01988311 Psilocybin · Hallucinogens · Pharmacologic Actions · Central Nervous System Agents · Therapeutic Uses · Psychotropic Drugs	Johns Hopkins University PHASE1	Completed Registry updated 2014-05-20	10 ESTIMATED	2013-05 2014-01 2014-05

Reported research facilities

Instituto de Fisica de Buenos Aires (IFIBA)Buenos Aires, Argentina · Coordinates available

CMAX Clinical ResearchAdelaide, South Australia, Australia · Coordinates available

CMAX Clinical Research Pty LtdAdelaide, South Australia, Australia · Coordinates available

Empax CentreLeederville, Western Australia, Australia · Coordinates available

Mind Medicine Australia ClinicAbbotsford, Victoria, Australia · Coordinates available

NeurocentrixMelbourne, Victoria, Australia · Coordinates available

Paratus Clinical Research MelbourneNorthcote, Victoria, Australia · Coordinates available

Ramsay Northside ClinicMelbourne, Victoria, Australia · Coordinates available

Medical University of Vienna, Department of Psychiatry and Psychotherapy, Division of General PsychiatryVienna, State of Vienna, Austria · Coordinates available

Brugmann University HospitalBrussels, Belgium · Coordinates available

Ghent University HospitalGhent, Oost-Vlaanderen, Belgium · Coordinates available

Centro de Pesquisas Matteo RicciRio de Janeiro, Rio de Janeiro, Brazil · Coordinates available

Federal University of Latin American IntegrationFoz do Iguaçu, Paraná, Brazil · Coordinates available

Arthur Child Comprehensive Cancer CentreCalgary, Alberta, Canada · Coordinates available

BCNorth Vancouver, British Columbia, Canada · Coordinates available

BioPharma Services Inc.Toronto, Ontario, Canada · Coordinates available

Bruyere Continuing CareOttawa, Ontario, Canada · Coordinates available

Bruyere HealthOttawa, Ontario, Canada · Coordinates available

Canadian Rapid Treatment Centre of ExcellenceMississauga, Ontario, Canada · Coordinates available

Canadian Rapid Treatment Centre of Excellence (CRTCE)Mississauga, Ontario, Canada · Coordinates available

Centre for Addiction and Mental HealthToronto, Ontario, Canada · Coordinates available

Centre for Addiction and Mental Health (CAMH)Toronto, Ontario, Canada · Coordinates available

Centre for Neurology StudiesVancouver, Canada · Coordinates available

Centre for Neurology StudiesSurrey, British Columbia, Canada · Coordinates available

Centre for Neurology Studies x UpstreamAbbotsford British Columbia, British Columbia, Canada · Coordinates available

Centricity ResearchHalifax, Nova Scotia, Canada · Coordinates available

Chatham-Kent Clnical Trials CentreChatham, Ontario, Canada · Coordinates available

Department of Psychiatry, Queen's UniversityKingston, Ontario, Canada · Coordinates available

Department of Psychiatry, University of Ottawa, The Ottawa HospitalOttawa, Ontario, Canada · Coordinates available

Department of Psychiatry, University of Toronto, University Health Network,Toronto, Ontario, Canada · Coordinates available

Diex Recherche Sherbrooke Inc.Québec, B.C., Canada · Coordinates available

Djavad Mowafaghian Centre for Brain HealthVancouver, British Columbia, Canada · Coordinates available

Halucenex Life Sciences Inc.Windsor, Nova Scotia, Canada · Coordinates available

Jewish General HospitalMontreal, Quebec, Canada · Coordinates available

KGK Science Inc.London, Ontario, Canada · Coordinates available

Kingston General Health Research InstituteKingston, Ontario, Canada · Coordinates available

MacAnxiety Research CentreHamilton, Ontario, Canada · Coordinates available

McGill University Health CentreMontreal, Quebec, Canada · Coordinates available

Medical Arts Health Research Centre, KamloopsKamloops, British Columbia, Canada · Coordinates available

Medical Arts Research GroupVancouver, Canada · Coordinates available

Medical Arts Research Group - PentictonPenticton, British Columbia, Canada · Coordinates available

Okanagan Clinical TrialsKelowna, British Columbia, Canada · Coordinates available

Princess Margaret Cancer CentreToronto, Ontario, Canada · Coordinates available

Providence Care HospitalKingston, Ontario, Canada · Coordinates available

Psych ResearchToronto, Ontario, Canada · Coordinates available

Queen's UniversityKingston, Ontario, Canada · Coordinates available

Sabi MindCalgary, Alberta, Canada · Coordinates available

South Lake Regional Health CentreNewmarket, Ontario, Canada · Coordinates available

St. Joseph's HealthcareLondon, Ontario, Canada · Coordinates available

St. Michael's HospitalToronto, Ontario, Canada · Coordinates available

St. Michael's Hospital, Unity Health TorontoToronto, Ontario, Canada · Coordinates available

St. Michael's Hospital. Unity Health TorontoToronto, Ontario, Canada · Coordinates available

Sunnybrook Health Sciences CentreToronto, Ontario, Canada · Coordinates available

The Ottawa HospitalOttawa, Ontario, Canada · Coordinates available

The University of British Columbia - Okanagan CampusKelowna, British Columbia, Canada · Coordinates available

Toronto General HospitalToronto, Ontario, Canada · Coordinates available

Toronto Western HospitalToronto, Ontario, Canada · Coordinates available

Toronto Western Hospital (University Health Network)Toronto, Ontario, Canada · Coordinates available

Toronto Western Hospital - University Health NetworkToronto, Ontario, Canada · Coordinates available

University Health NetworkToronto, Ontario, Canada · Coordinates available

University of British Columbia - Okanagan CampusKelowna, British Columbia, Canada · Coordinates available

University of British Columbia, Department of Psychiatry, BRAIN LabVancouver, British Columbia, Canada · Coordinates available

University of CalgaryCalgary, Alberta, Canada · Coordinates available

William Osler Health SystemBrampton, Ontario, Canada · Coordinates available

A-Shine s.r.o.Pilsen, Czechia · Coordinates available

Institut Neuropsychiatricke PecePrague, Czechia · Coordinates available

National Institute of Mental HealthKlecany, Czechia · Coordinates available

National Institute of Mental HealthPrague, Czechia · Coordinates available

National Institute of Mental Health Czech RepublicKlecany, Czechia · Coordinates available

Neuroterapie KH SroKutná Hora, Czechia · Coordinates available

Psychedelicka klinika, s.r.o.Prague, Czechia · Coordinates available

Psychiatric AmbulanceOstrava, Czechia · Coordinates available

Aalborg Universitetshospital-Psykiatrien Region NordjyllandAalborg, Denmark · Coordinates available

Bispebjerg HospitalCopenhagen, Denmark · Coordinates available

Enhed for Psykiatrisk Forskning, Psykiatrien i AalborgAalborg, Denmark · Coordinates available

Neurobiology Research Unit, RigshospitaletCopenhagen, Denmark · Coordinates available

Psychiatric Center CopenhagenCopenhagen, Frederiksberg, Denmark · Coordinates available

Psychiatric Center Copenhagen, Frederiksberg HospitalFrederiksberg, Denmark · Coordinates available

A-KlinikkaKouvola, Finland · Coordinates available

Addiktum OyTurku, Finland · Coordinates available

Mentacare OyOulu, Finland · Coordinates available

Research Center Oxidi Oy / Addiktum OyHelsinki, Finland · Coordinates available

CH Le VinatierBron, France · Coordinates available

CHUNîmes, Nîmes, France · Coordinates available

CHU BesançonBesançon, France · Coordinates available

CHU BrestBrest, France · Coordinates available

CHU Saint-EtienneSaint-Priest, France · Coordinates available

CHU de BordeauxBordeaux, France · Coordinates available

CHU de NantesNantes, France · Coordinates available

CHU de NîmesNîmes, France · Coordinates available

CHU de Nîmes, Hôpital Universitaire CarémeauNîmes, France · Coordinates available

Centre Hospitalier Sainte Anne - Clinique des Maladies Mentales et de l'Encephale (CMME)Paris, France · Coordinates available

Centre Hospitalier Universitaire de Nimes (CHU) - Hopital Universitaire CaremeauNîmes, France · Coordinates available

Centre Hospitalier de la Côte BasqueBayonne, France · Coordinates available

GHU Paris Psychiatrie and NeurosciencesParis, France · Coordinates available

Ghu-Centre Hospitalier Sainte Anne, Centre de Recherche CliniqueParis, Paris, France · Coordinates available

Nantes University HospitalNantes, France · Coordinates available

Universite Paris VI Pierre et Marie Curie - Hopital de La Salpetriere - Centre Emotion - USR 3246 (CNRS UMR 7593)Paris, France · Coordinates available

Central Institute of Mental Health (CIMH)Mannheim, Germany · Coordinates available

Charite-Universitaetsmedizin BerlinBerlin, Germany · Coordinates available

Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin FranklinBerlin, Germany · Coordinates available

Charité Berlin, Campus Mitte, Department of Psychiatry and PsychotherapyBerlin, Germany · Coordinates available

Johann Wolfgang Goethe-Universitaet Frankfurt am Main - Klinik fuer Psychiatrie, Psychosomatik und PsychotherapieFrankfurt, Germany · Coordinates available

ZiP Campus LuebeckLübeck, Germany · Coordinates available

La Nua Day Hospital Mental Health CentreGalway, Ireland · Coordinates available

Sheaf House, Tallaght HospitalDublin, Ireland · Coordinates available

Tallaght University HospitalDublin, Ireland · Coordinates available

Beer Sheva Mental Health CenterBeersheba, Israel · Coordinates available

Hadassah Medical Organization, Jerusalem, IsraelJerusalem, Israel · Coordinates available

Mental Health Center Beer ShevaBeersheba, Israel · Coordinates available

Tel Aviv Sourasky Medical CenterTel Aviv, Israel · Coordinates available

FMS Department of PsychiatryKingston, Jamaica · Coordinates available

Pharmaceutical Research UnitAmman, Jordan · Coordinates available

ARQ National Psychotrauma Centre / ARQ Centrum'45Oegstgeest, Netherlands · Coordinates available

Groningen University Medical CentreGroningen, Netherlands · Coordinates available

Leiden University Medical CenterLeiden, South Holland, Netherlands · Coordinates available

Leiden University Medical CentreLeiden, Netherlands · Coordinates available

Leids Universitair Medisch Centrum (LUMC) (Leiden University Medical Center) - Leiden Institute for Brain and Cognition (LIBC)Leiden, Netherlands · Coordinates available

Maastricht UniversityMaastricht, Limburg, Netherlands · Coordinates available

Universitair Medisch Centrum Utrecht (UMC Utrecht)Utrecht, Netherlands · Coordinates available

University Medical Center GroningenGroningen, Netherlands · Coordinates available

University Medical Center GroningenGroningen, Provincie Groningen, Netherlands · Coordinates available

Utrecht University Medical CentreUtrecht, Netherlands · Coordinates available

University of OtagoChristchurch, New Zealand · Coordinates available

Hayatabad Medical Complex PeshawarPeshawar, KPK, Pakistan · Coordinates available

Institute of Health Science, Khyber Medical UniversityIslamabad, Capital, Pakistan · Coordinates available

Khyber Medical UniversityPeshawar, KPK, Pakistan · Coordinates available

Lady Reading Hospital, PakistanPeshawar, Khyber Pakhtunkhwa, Pakistan · Coordinates available

Centrum Badan Klinicznych PI-House Sp. z o.o.Gdansk, Poland · Coordinates available

Promente - Ośrodek Badań KlinicznychBydgoszcz, Poland · Coordinates available

Uniwersyteckle Centrum Kliniczne, Klinika Psychiatrii DoroslychGdansk, Poland · Coordinates available

Champalimaud FoundationLisbon, Portugal · Coordinates available

Unidade de Neuropsiquiatria, Centro Clinico ChampalimaudLisbon, Portugal · Coordinates available

FIDMAG Hermanas HospitalariasSant Boi de Llobregat, Spain · Coordinates available

Hospital Clinic de BarcelonaBarcelona, Spain · Coordinates available

Hospital Provincial de Zamora - Servicio de PsiquiatriaZamora, Spain · Coordinates available

Hospital Universitario Fundacion Jimenez DiazMadrid, Spain · Coordinates available

Hospital Universitario Río Hortega de ValladolidValladolid, Spain · Coordinates available

Hospital de Dia NumanciaBarcelona, Spain · Coordinates available

Institute Hospital del Mar of Medical Research (IMIM)Barcelona, Spain · Coordinates available

Parc Sanitari Sant Joan de Deu (Sant Joan de Deu Serveis de Salut Mental)Barcelona, Spain · Coordinates available

ClinSmart Sweden ABSolna, Sweden · Coordinates available

HälsoklustretStockholm, Sweden · Coordinates available

Lunds Universitet - Medicinska Fakulteten (Lund University Faculty of Medicine)Lund, Sweden · Coordinates available

Norra Stockholms PsykiatriStockholm, Stockholm County, Sweden · Coordinates available

Northern Stockholm Spychiatry ClinicStockholm, Sweden · Coordinates available

Psykiatrikliniken, Baravägen 1Lund, Sweden · Coordinates available

Psykiatriska Kliniken, Akademiska SjukhusetUppsala, Uppsala County, Sweden · Coordinates available

VuxenpsykiatrimottagningenLandskrona, Sweden · Coordinates available

region Västra GötalandGothenburg, Göteborg, Sweden · Coordinates available

Örebro sjukhusÖrebro, Örebro County, Sweden · Coordinates available

Clinical Pharmacology & Toxicology, University Hospital BaselBasel, Basel, Switzerland · Coordinates available

Clinical Pharmacology & Toxicology, University Hospital BaselBasel, Switzerland · Coordinates available

Clinical Trial UnitBasel, Canton of Basel-City, Switzerland · Coordinates available

Department of Nuclear Medicine, Bern University HospitalBern, Switzerland · Coordinates available

Geneva University HospitalGeneva, Switzerland · Coordinates available

Private Practice P.GasserSolothurn, Canton of Solothurn, Switzerland · Coordinates available

Psychiatric University Hospital ZurichZurich, Switzerland · Coordinates available

Psychiatrische Universitätsklinik ZürichZurich, Canton of Zurich, Switzerland · Coordinates available

Psychiatrische Universitätsklinik ZürichZurich, Switzerland · Coordinates available

Spital Uster AG, Division of Internal MedicineUster, Switzerland · Coordinates available

University HospitalBasel, Switzerland · Coordinates available

University Hospital BaselBasel, Switzerland · Coordinates available

University Hospital BaselBasel, Canton of Basel-City, Switzerland · Coordinates available

University Hospital Basel, Clinical Trial UnitBasel, Canton of Basel-City, Switzerland · Coordinates available

University Hospital Basel, Division of Clinical Pharmacology and ToxicologyBasel, Switzerland · Coordinates available

University Hospital Geneva, Palliative medicine departmentCollonge-Bellerive, Switzerland · Coordinates available

University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative CareZurich, Switzerland · Coordinates available

Universtity Hospital BaselBasel, Switzerland · Coordinates available

Abraham Cowley Unit - Surrey and Borders Partnership NHS Foundation TrustChertsey, United Kingdom · Coordinates available

CIPPRes ClinicLondon, United Kingdom · Coordinates available

Clerkenwell HealthLondon, United Kingdom · Coordinates available

Clinical Research Facility, King's College HospitalLondon, London, United Kingdom · Coordinates available

Clinical Research Facility, Royal Devon and Exeter HospitalExeter, United Kingdom · Coordinates available

Clinical Research and Imaging CentreBristol, Avon, United Kingdom · Coordinates available

Combat StressLeatherhead, Surrey, United Kingdom · Coordinates available

Cornwall Partnership NHS Foundation TrustBodmin, Cornwall, United Kingdom · Coordinates available

Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust - Wolfson Research CentreNewcastle, United Kingdom · Coordinates available

Fulbourn Hospital - Cambridgeshire And Peterborough NHS Foundation TrustFulbourn, United Kingdom · Coordinates available

Greater Manchester Mental Health Foundation TrustManchester, United Kingdom · Coordinates available

Grounded Research Hub - Rotherham Doncaster & South Humber NHS Foundation TrustDoncaster, United Kingdom · Coordinates available

Hammersmith Medicines Research (HMR)London, United Kingdom · Coordinates available

Imperial College Hammersmith campusLondon, United Kingdom · Coordinates available

Imperial College LondonLondon, United Kingdom · Coordinates available

King's College LondonLondon, United Kingdom · Coordinates available

King's College London - Institute of Psychiatry, PsychologyLondon, United Kingdom · Coordinates available

King's College London Institute of Psychiatry, Psychology and NeuroscienceLondon, United Kingdom · Coordinates available

Kings College London, Institute of Psychiatry, Psychology and NeurologyLondon, United Kingdom · Coordinates available

Mitul MehtaLondon, Camberwell, United Kingdom · Coordinates available

Sheffield Health and Social Care NHS Foundation TrustSheffield, United Kingdom · Coordinates available

South London and Maudsley NHS Foundation TrustLondon, United Kingdom · Coordinates available

St. Pancras Clinical ResearchChester, United Kingdom · Coordinates available

St. Pancras Clinical ResearchLondon, United Kingdom · Coordinates available

The Warneford Hospital- NIHR Clinical Research FacilityOxford, United Kingdom · Coordinates available

University College LondonLondon, United Kingdom · Coordinates available

University Of Nottingham/Nottinghamshire Healthcare Trust, Institute Of Mental HealthNottingham, United Kingdom · Coordinates available

Wolfson Research Centre, Campus for Ageing and VitalityNewcastle upon Tyne, Tyne and Wear, United Kingdom · Coordinates available

5510 Nathan Shock DriveBaltimore, Maryland, United States · Coordinates available

AIM Trials, LLCPlano, Texas, United States · Coordinates available

APG Research, LLCOrlando, Florida, United States · Coordinates available

APG Research, LLC- Advanced Psychiatric GroupOrlando, Florida, United States · Coordinates available

ASCLEPES Research CentersThousand Oaks, California, United States · Coordinates available

ATP Clinical Research, Inc.Orange, California, United States · Coordinates available

AZTucson, Arizona, United States · Coordinates available

Adams Clinical - BostonWatertown, Massachusetts, United States · Coordinates available

Adams Clinical - Boston (Copley Clinical)Boston, Massachusetts, United States · Coordinates available

Adams Clinical - New YorkNew York, New York, United States · Coordinates available

Adams Clinical - New YorkThe Bronx, New York, United States · Coordinates available

Aims TrialPlano, Texas, United States · Coordinates available

Alivation Research, LLC.Lincoln, Nebraska, United States · Coordinates available

Altasciences Clinical Kansas, IncOverland Park, Kansas, United States · Coordinates available

Altman Clinical and Translational Research InstituteSan Diego, California, United States · Coordinates available

Altman Clinical and Translational Research InstituteLa Jolla, California, United States · Coordinates available

Altman Clinical and Translational Research Institute, University of CaliforniaSan Diego, California, United States · Coordinates available

Artemis Institute for Clinical ResearchSan Diego, California, United States · Coordinates available

Athinoula A. Martinos Center for Biomedical ImagingCharlestown, Massachusetts, United States · Coordinates available

Atlanta Center for Medical ResearchAtlanta, Georgia, United States · Coordinates available

Baylor College of MedicineHouston, Texas, United States · Coordinates available

Behavioral Biology Research Center, Johns Hopkins BayviewBaltimore, Maryland, United States · Coordinates available

Behavioral Clinical Research, Inc.Miami Lakes, Florida, United States · Coordinates available

Behavioral Pharmacology Research UnitBaltimore, Maryland, United States · Coordinates available

Behavioral Pharmacology Research Unit, Johns Hopkins Bayview CampusBaltimore, Maryland, United States · Coordinates available

Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical CenterBaltimore, Maryland, United States · Coordinates available

Bio Behavioral HealthToms River, New Jersey, United States · Coordinates available

Birmingham VA Medical Center, Birmingham, ALBirmingham, Alabama, United States · Coordinates available

Brain Health Center at Executive ParkAtlanta, Georgia, United States · Coordinates available

Brain Health Consultants and TMS CenterHouston, Texas, United States · Coordinates available

Brigham and Women's HospitalBoston, Massachusetts, United States · Coordinates available

Bronx Veterans Research Foundation at the James J. Peters VAMCThe Bronx, New York, United States · Coordinates available

Brown University School of Public HealthProvidence, Rhode Island, United States · Coordinates available

CBH Health, LLCGaithersburg, Maryland, United States · Coordinates available

CITrialsRiverside, California, United States · Coordinates available

CalNeuro Research Group, IncLos Angeles, California, United States · Coordinates available

California Center for Psychedelic TherapyLos Angeles, California, United States · Coordinates available

Care DimensionsDanvers, Massachusetts, United States · Coordinates available

Catalina Research Institute, LLCMontclair, California, United States · Coordinates available

Cedar Clinical ResearchDraper, Utah, United States · Coordinates available

Cedar Clinical Research, Inc.Murray, Utah, United States · Coordinates available

CenExel iResearch, LLCDecatur, Georgia, United States · Coordinates available

Center for Depression Research and Clinical CareDallas, Texas, United States · Coordinates available

Center for Psychedelics and Consciousness ResearchBaltimore, Maryland, United States · Coordinates available

Center for Psychedelics and Consciousness Research in the Behavioral Biology Research CenterBaltimore, Maryland, United States · Coordinates available

Central Miami Medical Institute, LLCMiami, Florida, United States · Coordinates available

Chronic Pain and Fatigue Research CenterAnn Arbor, Michigan, United States · Coordinates available

Clarity Clinical Research, LLCLos Angeles, California, United States · Coordinates available

Cleveland Clinic - Lutheran HospitalCleveland, Ohio, United States · Coordinates available

Clinical Innovations, Inc.Bellflower, California, United States · Coordinates available

Clinical Neurosciecne Solutions, Inc. dba CNS HealthcareOrlando, Florida, United States · Coordinates available

Clinical Neuroscience Solutions IncJacksonville, Florida, United States · Coordinates available

Clinical Neuroscience Solutions Inc.Jacksonville, Florida, United States · Coordinates available

Clinical Neuroscience Solutions, Inc.Orlando, Florida, United States · Coordinates available

Clinical Trials of Texas, LLCSan Antonio, Texas, United States · Coordinates available

Clinical and Translational Science Institute, NYU Langone Medical CenterNew York, New York, United States · Coordinates available

Collaborative Neuroscience Network, LLCGarden Grove, California, United States · Coordinates available

Comprehensive Psychiatric CareNorwich, Connecticut, United States · Coordinates available

Connecticut Mental Health CenterNew Haven, Connecticut, United States · Coordinates available

Connecticut Mental Health CenterHamden, Connecticut, United States · Coordinates available

Connecticut Mental Health Center - Yale School of MedicineNew Haven, Connecticut, United States · Coordinates available

Connecticut Mental Health Center, Yale UniversityNew Haven, Connecticut, United States · Coordinates available

Core Clinical ResearchEverett, Washington, United States · Coordinates available

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PAPhiladelphia, Pennsylvania, United States · Coordinates available

DMI Health Care Group, IncTampa, Florida, United States · Coordinates available

Dana-Farber Cancer InstituteBoston, Massachusetts, United States · Coordinates available

Dell Medical SchoolAustin, Texas, United States · Coordinates available

Dent Neurosciences Research Center, Inc.Amherst, New York, United States · Coordinates available

Department of Veterans AffairsWest Haven, Connecticut, United States · Coordinates available

Duke City Recovery ToolboxAlbuquerque, New Mexico, United States · Coordinates available

Elixia MA, LLCSpringfield, Massachusetts, United States · Coordinates available

Emory UniversityAtlanta, Georgia, United States · Coordinates available

Emory University Brain Health CenterAtlanta, Georgia, United States · Coordinates available

Emory University HospitalAtlanta, Georgia, United States · Coordinates available

Emory University/Winship Cancer InstituteAtlanta, Georgia, United States · Coordinates available

Enact Research CollaborativeNew Haven, Connecticut, United States · Coordinates available

Enact Research Collaborative (40 Temple St, 4th Floor)New Haven, Connecticut, United States · Coordinates available

FLMiami, Florida, United States · Coordinates available

FLOrlando, Florida, United States · Coordinates available

Fieve Clinical Research, IncNew York, New York, United States · Coordinates available

Fred Hutch/University of Washington Cancer ConsortiumSeattle, Washington, United States · Coordinates available

Global Medical Institutes, LLC, Scranton Medical InstituteMoosic, Pennsylvania, United States · Coordinates available

Global Medical Institutes, LLC; Princeton Medical InstitutePrinceton, New Jersey, United States · Coordinates available

Goodman Hall, Dept of Psychiatry, Indiana UniversityIndianapolis, Indiana, United States · Coordinates available

Great Lakes Clinical TrialsChicago, Illinois, United States · Coordinates available

HCA Healthcare Research Institute - Medical City Green Oaks HospitalPlano, Texas, United States · Coordinates available

Harbor-UCLA Medical CenterTorrance, California, United States · Coordinates available

Harvard Medical School - McLean HospitalBelmont, Massachusetts, United States · Coordinates available

Hassman Research InstituteBerlin, New Jersey, United States · Coordinates available

Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600Austin, Texas, United States · Coordinates available

Health Synergy Clinical ResearchOkeechobee, Florida, United States · Coordinates available

Health Synergy Clinical Research, LLCWest Palm Beach, Florida, United States · Coordinates available

Houston Clinical Trials, LLCBellaire, Texas, United States · Coordinates available

Huntsman Cancer InstituteSalt Lake City, Utah, United States · Coordinates available

Huntsman Mental Health InstituteSalt Lake City, Utah, United States · Coordinates available

ILChicago, Illinois, United States · Coordinates available

Icahn School of Medicine at Mount SinaiNew York, New York, United States · Coordinates available

Icahn School of Medicine at Mount Sinai, Center for Psychedelic Therapy ResearchNew York, New York, United States · Coordinates available

Innertrek Patient Service CenterPortland, Oregon, United States · Coordinates available

Innovative Clinical Research, Inc.Lauderhill, Florida, United States · Coordinates available

Innovative Clinical Research, Inc. (formerly Segal Trials)Lauderhill, Florida, United States · Coordinates available

Insight Clinical Trials, LLCBeachwood, Ohio, United States · Coordinates available

Institute for Integrative TherapiesEden Prairie, Minnesota, United States · Coordinates available

Interdisciplinary Substance Use and Brain Injury (ISUBI)Albuquerque, New Mexico, United States · Coordinates available

James J. Peters Department of Veterans Affairs Medical CenterThe Bronx, New York, United States · Coordinates available

Johns HopkinsBaltimore, Maryland, United States · Coordinates available

Johns Hopkins Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States · Coordinates available

Johns Hopkins School of MedicineBaltimore, Maryland, United States · Coordinates available

Johns Hopkins School of Medicine, Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States · Coordinates available

Johns Hopkins UniversityBaltimore, Maryland, United States · Coordinates available

Johns Hopkins University School of MedicineBaltimore, Maryland, United States · Coordinates available

Kadima Neuropsychiatry InstituteLa Jolla, California, United States · Coordinates available

LSU Health ShreveportShreveport, Louisiana, United States · Coordinates available

Lighthouse Psychiatry ScottsdaleGilbert, Arizona, United States · Coordinates available

Lumos Clinical Research CenterSan Jose, California, United States · Coordinates available

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterTorrance, California, United States · Coordinates available

M Health Fairview DBT ProgramMinneapolis, Minnesota, United States · Coordinates available

M Physicians St. Louis Park ClinicSaint Louis Park, Minnesota, United States · Coordinates available

M3 Wake ResearchEncino, California, United States · Coordinates available

MD Anderson Cancer CenterHouston, Texas, United States · Coordinates available

MNEden Prairie, Minnesota, United States · Coordinates available

Marin Cancer CareGreenbrae, California, United States · Coordinates available

Maryland Oncology Hematology PARockville, Maryland, United States · Coordinates available

Massachusetts General HospitalBoston, Massachusetts, United States · Coordinates available

Meridien Research/Accel ResearchTampa, Florida, United States · Coordinates available

Michigan Clinical Research Institute PCAnn Arbor, Michigan, United States · Coordinates available

Midwest Research GroupSaint Charles, Missouri, United States · Coordinates available

Minneapolis VA Health Care System, Minneapolis, MNMinneapolis, Minnesota, United States · Coordinates available

Mood and Anxiety Disorders Program Emory University School of MedicineAtlanta, Georgia, United States · Coordinates available

Mount Sinai Comprehensive Cancer CenterMiami Beach, Florida, United States · Coordinates available

Mountain View Clinical ResearchDenver, Colorado, United States · Coordinates available

NELincoln, Nebraska, United States · Coordinates available

NVLas Vegas, Nevada, United States · Coordinates available

NYNew York, New York, United States · Coordinates available

NYThe Bronx, New York, United States · Coordinates available

NYU Clinical & Translational Science InstituteNew York, New York, United States · Coordinates available

NYU College of Dentistry Bluestone Center for Clinical ResearchNew York, New York, United States · Coordinates available

NYU Langone HealthNew York, New York, United States · Coordinates available

NYU Langone Medical Center/Tisch HospitalNew York, New York, United States · Coordinates available

National Institute of Aging, Clinical Research UnitBaltimore, Maryland, United States · Coordinates available

National University of Natural MedicinePortland, Oregon, United States · Coordinates available

Neuro-Behaviroral Clinical Research, Inc.North Canton, Ohio, United States · Coordinates available

Neuroimaging Research Branch, NIDA-IRPBaltimore, Maryland, United States · Coordinates available

New York State Psychiatric InstituteNew York, New York, United States · Coordinates available

New York State Psychiatric Institute, 1051 Riverside DriveNew York, New York, United States · Coordinates available

New York UniversityNew York, New York, United States · Coordinates available

New York University Langone Health, Center for Psychedelic MedicineNew York, New York, United States · Coordinates available

New York University School of MedicineNew York, New York, United States · Coordinates available

North Texas Clinical TrialsFort Worth, Texas, United States · Coordinates available

Ohio State University Comprehensive Cancer CenterColumbus, Ohio, United States · Coordinates available

Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research CenterColumbus, Ohio, United States · Coordinates available

Olin Neuropsychiatry Research CenterHartford, Connecticut, United States · Coordinates available

Oregon Health & Science UniversityPortland, Oregon, United States · Coordinates available

Outpatient CTRCAurora, Colorado, United States · Coordinates available

Pacific Clinical Research Management Group, LLCUpland, California, United States · Coordinates available

Pacific Neuroscience InstituteSanta Monica, California, United States · Coordinates available

Pacific Neuroscience Institute (PNI) at Saint John's Physician PartnersSanta Monica, California, United States · Coordinates available

Pacific Treatment & Research in PsychedelicsSanta Monica, California, United States · Coordinates available

Pharmasite Research, IncPikesville, Maryland, United States · Coordinates available

Piedmont Hospital Neuroscience CentreOakland, California, United States · Coordinates available

Portland VA Health Care SystemVancouver, Washington, United States · Coordinates available

Preferred Research Partners, Inc.Little Rock, Arkansas, United States · Coordinates available

Preferred Research Partners-NWA, LLCFayetteville, Arkansas, United States · Coordinates available

Princeton Medical InstitutePrinceton, New Jersey, United States · Coordinates available

ProScience Research GroupCulver City, California, United States · Coordinates available

Psych AtlantaAtlanta, Georgia, United States · Coordinates available

Psychedelic Science InstituteSanta Monica, California, United States · Coordinates available

Psychiatric Medicine AssociatesSkokie, Illinois, United States · Coordinates available

Ray Worthy Psychiatry LLCNew Orleans, Louisiana, United States · Coordinates available

Relaro Medical TrialsDallas, Texas, United States · Coordinates available

Richmond Behavioral AssociatesStaten Island, New York, United States · Coordinates available

Rivus Wellness & Research InstituteOklahoma City, Oklahoma, United States · Coordinates available

Ross Allison NPI #1437519899 Administrator Of StudyBozeman, Montana, United States · Coordinates available

Roswell Park Cancer InstituteBuffalo, New York, United States · Coordinates available

Rush University Medical CenterChicago, Illinois, United States · Coordinates available

San Francisco VA Medical Center, San Francisco, CASan Francisco, California, United States · Coordinates available

Scottsdale Research InstituteScottsdale, Arizona, United States · Coordinates available

Seattle Neuropsychiatric Treatment CenterBellevue, Washington, United States · Coordinates available

Seattle Neuropsychiatric Treatment CenterSeattle, Washington, United States · Coordinates available

Segal TrialsLauderhill, Florida, United States · Coordinates available

Sheppard PrattBaltimore, Maryland, United States · Coordinates available

Sheppard Pratt Health SystemBaltimore, Maryland, United States · Coordinates available

Spectrum Neuroscience and Treatment InstituteNew York, New York, United States · Coordinates available

St. Charles Psychiatric Associates - Midwest Research GroupSaint Charles, Missouri, United States · Coordinates available

Stanford Department of PsychiatryStanford, California, United States · Coordinates available

Stanford UniversityStanford, California, United States · Coordinates available

StartCareBrooklyn, New York, United States · Coordinates available

Stedman Clinical TrialsTampa, Florida, United States · Coordinates available

Suburban Research AssociatesMedia, Pennsylvania, United States · Coordinates available

Sunstone Medical PCRockville, Maryland, United States · Coordinates available

Sunstone Medical, PCRockville, Maryland, United States · Coordinates available

Sunstone TherapiesRockville, Maryland, United States · Coordinates available

Syrentis Clinical ResearchSanta Ana, California, United States · Coordinates available

The Clinical and Translational Sciences Research CenterTucson, Arizona, United States · Coordinates available

The Medical Research Network, LLCNew York, New York, United States · Coordinates available

The Ohio State UniversityColumbus, Ohio, United States · Coordinates available

The Ohio State University Department of PsychiatryColumbus, Ohio, United States · Coordinates available

The Ohio State University Medical CenterColumbus, Ohio, United States · Coordinates available

The Parsons Research Center for Psychedelic HealingNew York, New York, United States · Coordinates available

The Regents of the University of California - San DiegoLa Jolla, California, United States · Coordinates available

The Stark Neuroscience Building (Goodman Hall)Indianapolis, Indiana, United States · Coordinates available

The University of Texas Health Science Center at HoustonHouston, Texas, United States · Coordinates available

The University of Texas M. D. Anderson Cancer CenterHouston, Texas, United States · Coordinates available

The University of Texas at Austin - Dell Medical SchoolAustin, Texas, United States · Coordinates available

The University of Texas at Austin Dell Medical SchoolAustin, Texas, United States · Coordinates available

The University of Utah - Huntsman Mental Health InstituteSalt Lake City, Utah, United States · Coordinates available

Tuscaloosa VA Medical Center, Tuscaloosa, ALTuscaloosa, Alabama, United States · Coordinates available

UAB Beacon TowerBirmingham, Alabama, United States · Coordinates available

UAB Outpatient Clinical Research UnitBirmingham, Alabama, United States · Coordinates available

UC San DiegoSan Diego, California, United States · Coordinates available

UCLA Semel InstituteLos Angeles, California, United States · Coordinates available

UCSF Mission BaySan Francisco, California, United States · Coordinates available

UCSF at Zuckerberg San Francisco General HospitalSan Francisco, California, United States · Coordinates available

UNC Chapel Hill Medical CenterChapel Hill, North Carolina, United States · Coordinates available

UPMC PresbyterianPittsburgh, Pennsylvania, United States · Coordinates available

UT Center of Excellence on Mood Disorders, University of Texas Health Science CenterHouston, Texas, United States · Coordinates available

UT Health Science Center at Houston (UTHSC-H)Houston, Texas, United States · Coordinates available

UW School of Medicine and Public HealthMadison, Wisconsin, United States · Coordinates available

UWHealth, 600 Highland AvenueMadison, Wisconsin, United States · Coordinates available

Univeristy of Southern California Brain and Creativity InstituteLos Angeles, California, United States · Coordinates available

University California San DiegoLa Jolla, California, United States · Coordinates available

University Of Michigan Comprehensive Depression CenterAnn Arbor, Michigan, United States · Coordinates available

University South FloridaTampa, Florida, United States · Coordinates available

University of Alabama Clinical Research UnitBirmingham, Alabama, United States · Coordinates available

University of Alabama at BirminghamBirmingham, Alabama, United States · Coordinates available

University of ArizonaTucson, Arizona, United States · Coordinates available

University of Arizona-TucsonTucson, Arizona, United States · Coordinates available

University of California San FranciscoSan Francisco, California, United States · Coordinates available

University of California San Francisco (UCSF) Department of NeurologySan Francisco, California, United States · Coordinates available

University of California San Francisco, Sandler Neuroscience BuildingSan Francisco, California, United States · Coordinates available

University of California, BerkeleyBerkeley, California, United States · Coordinates available

University of California, Los AngelesLos Angeles, California, United States · Coordinates available

University of California, San DiegoSan Diego, California, United States · Coordinates available

University of California, San FranciscoSan Francisco, California, United States · Coordinates available

University of ChicagoChicago, Illinois, United States · Coordinates available

University of Cincinnati, Department of Psychiatry & Behavirol NeuroscienceCincinnati, Ohio, United States · Coordinates available

University of Colorado Anschutz Medical CampusAurora, Colorado, United States · Coordinates available

University of Colorado Anschutz Medical campus (CU AMC)Aurora, Colorado, United States · Coordinates available

University of Colorado Cancer CenterAurora, Colorado, United States · Coordinates available

University of FloridaGainesville, Florida, United States · Coordinates available

University of IowaIowa City, Iowa, United States · Coordinates available

University of Iowa Health CareIowa City, Iowa, United States · Coordinates available

University of Massachusetts Medical SchoolNorth Worcester, Massachusetts, United States · Coordinates available

University of MinnesotaMinneapolis, Minnesota, United States · Coordinates available

University of MissouriColumbia, Missouri, United States · Coordinates available

University of Nebraska Medical CenterOmaha, Nebraska, United States · Coordinates available

University of New MexicoAlbuquerque, New Mexico, United States · Coordinates available

University of New Mexico (UNM) Interdisciplinary Substance Use and Brain Injury (ISUBI) CenterAlbuquerque, New Mexico, United States · Coordinates available

University of New Mexico Health Sciences CenterAlbuquerque, New Mexico, United States · Coordinates available

University of PennsylvaniaPhiladelphia, Pennsylvania, United States · Coordinates available

University of San FranciscoSan Francisco, California, United States · Coordinates available

University of VirginiaCharlottesville, Virginia, United States · Coordinates available

University of WashingtonSeattle, Washington, United States · Coordinates available

University of Washington Center for Novel Therapeutics in Addiction PsychiatrySeattle, Washington, United States · Coordinates available

University of WisconsinMadison, Wisconsin, United States · Coordinates available

University of Wisconsin - MadisonMadison, Wisconsin, United States · Coordinates available

University of Wisconsin Hospital and ClinicsMadison, Wisconsin, United States · Coordinates available

University of Wisconsin, School of PharmacyMadison, Wisconsin, United States · Coordinates available

Uptown Research Institute, LLCChicago, Illinois, United States · Coordinates available

VA Connecticut Healthcare SystemWest Haven, Connecticut, United States · Coordinates available

VA Connecticut Healthcare System, West Haven CampusWest Haven, Connecticut, United States · Coordinates available

VA Nebraska Western Iowa Health Care SystemOmaha, Nebraska, United States · Coordinates available

VA Palo Alto Healthcare System/Stanford MedicinePalo Alto, California, United States · Coordinates available

VA Portland Health Care SystemVancouver, Washington, United States · Coordinates available

VA Portland Health Care System, Portland, ORPortland, Oregon, United States · Coordinates available

VA Puget Sound Health Care System Seattle Division, Seattle, WASeattle, Washington, United States · Coordinates available

VA Salt Lake City Health Care System, Salt Lake City, UTSalt Lake City, Utah, United States · Coordinates available

VA San Diego Healthcare System, San Diego, CASan Diego, California, United States · Coordinates available

VIP Community Services, IncThe Bronx, New York, United States · Coordinates available

Vail Health Behavioral HealthEdwards, Colorado, United States · Coordinates available

Washington UniversitySt Louis, Missouri, United States · Coordinates available

Washington University School of MedicineSt Louis, Missouri, United States · Coordinates available

West Haven VA Medical CenterWest Haven, Connecticut, United States · Coordinates available

West LA VA Medical Center - Mental Health DepartmentLos Angeles, California, United States · Coordinates available

Yale Program for Psychedelic ResearchNew Haven, Connecticut, United States · Coordinates available

Yale UniversityNew Haven, Connecticut, United States · Coordinates available

iResearch AtlantaDecatur, Georgia, United States · Coordinates available

This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.